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ABSTRACT
This study examined the physiological and psychological stressors of hospitalized acute
myocardial infarction (AMI) patients who abruptly ceased smoking. A cross-sectional
survey was conducted on 57 AMI patients (29 smokers and 29 non-smokers) on day two
following admission to the coronary care unit. Psychological stress was measured using the
Profile of Mood States and the Insomnia Severity Index. Retrospective chart abstraction
was conducted to examine the impact of smoking cessation on the physiological outcomes.
MANCOVA suggested that after adjusting for age, smokers experienced significantly
higher levels of depression, anxiety and anger as compared to the non-smokers. Student ttests and chi-square analyses revealed no differences in length of stay, ischemia and
arrhythmia between the two groups. The findings support some propositions of the
Transactional Model of Stress and Coping, and offer support for continued assessment and
research related to the management of nicotine withdrawal following AMI.
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CHAPTER 1
INTRODUCTION
The experience of acute myocardial infarction (AMI) represents a time of stress in
terms of both emotional impact and lifestyle change (Fleury & Moore, 1999; Stewart,
Davidson, Meade, Hirth, & Makrides, 2000). This is particularly true among hospitalized
patients (De Jong, Moser, An, & Misock., 2005; Grace et al., 2005; Mayou et al., 2000).
When hospitalized, AMI patients who routinely engage in smoking are unable to utilize
tobacco as a possible means of coping. This is problematic for these individuals given
that smoking has been reported by post-AMI patients as a means of coping with stressful
situations (Bennett, Lowe, Mayfield, & Morgan, 1999). In addition, when smokers cease
utilizing tobacco, they experience symptoms of withdrawal, which is also associated with
anxiety and depression (Hughes, 1992; Gritz, Carr, & Marcus, 1991). The simultaneous
convergence of these events may result in physiological and psychological effects that
could be detrimental to hospitalized AMI patients. Therefore, determining the impact of
abrupt nicotine withdrawal on this population may provide greater insight into the stress
and coping of smoking AMI patients. Furthermore, identification of the stressors and
coping strategies utilized by AMI patients may assist clinicians and educators to design
and implement evidence-based interventions to assist coping during this uncertain time.
Finally, the introduction of early interventions to minimize the effects of nicotine
withdrawal and facilitate smoking cessation may reduce associated morbidity and
mortality in this patient population.
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Significance of the Problem
In Canada, heart disease is not only the number one cause of death, but it
represents the most significant burden on the national health care system (Health Canada,
2007). When compared to the rest of the country, the direct and indirect costs associated
with the treatment of cardiovascular disease in Ontario are significantly greater than all
other Canadian provinces (Public Health Agency of Canada, 2003). Smoking represents a
significant risk factor for ischemic heart disease. In fact, smokers are two to three times
more likely to die from coronary heart disease (CHD) than non-smokers (American Heart
Association, 2005). Statistics reveal that in 1998,22% of all deaths in Canada were
related to smoking (Makomaski Illing & Kaiserman, 2004). Of these smoking-related
deaths, ischemic heart disease was the second highest cause of death.
The issue of CHD and smoking is of considerable concern in Windsor-Essex
County. In this population, ischemic heart disease is the leading cause of death in men
and women (Windsor-Essex County Health Unit, 2003). In fact, the Windsor-Essex
County Health Unit reported that among women, the rate of coronary artery disease
(CAD) in Windsor is 29% higher than the provincial average, with the rate among men
being 28% higher than the provincial average. It also reported that 26% of adult males,
24% of adult females and 33% of teens smoke on a daily basis. VanderKaay and
Patterson (2006) suggested that individuals who smoke one pack of cigarettes per day
have a two and a half times greater chance of developing CHD than non-smokers.
Further, Mehta and Eagle (1998) suggested that smoking increases the risk of an initial
cardiac event and doubles the rate of a subsequent infarction.
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There is strong clinical evidence suggesting that smoking cessation is probably
the single-most powerful lifestyle intervention with regard to the prevention of
cardiovascular disease (CVD) (American Heart Association, 2005; European Society of
Hypertension, 2003). In fact, it has been suggested that smoking cessation results in a
50% decrease in mortality and morbidity associated with CVD (American Heart
Association; Dalai, Evans, & Campbell, 2004; Wilson, Gibson, Willan, & Cook, 2000).
Furthermore, quitting smoking reduces the risk of a second heart attack or sudden death
by 20 to 50 percent among individuals who have suffered AMI (Critchley & Capewell,
2003; Heart and Stroke Foundation, 2002).
Due to the addictive nature of nicotine, smoking cessation remains a difficult
process. The Centers for Disease Control and Prevention (2006) suggested that most
individuals engage in two to three attempts, or more, before achieving success. In fact, it
has been reported (University of Wisconsin Center for Tobacco Research and
Intervention, 2004) that 90% of abrupt smoking cessation attempts are unsuccessful. This
is probably due to the fact that the onset of nicotine withdrawal can occur within only a
few hours after the last cigarette consumed, with peak symptoms occurring within a few
days and lasting up to several weeks (Gritz et al, 1991). These symptoms often include
anxiety, stress, irritability, depression, decreased concentration, insomnia, headache and
tightness in the chest (Health Canada, 2005; VanderKaay & Patterson, 2006).
Interestingly, stress has been cited as a trigger for relapse among those who are
attempting to quit smoking (Heart and Stroke Foundation, 2001). Furthermore, studies
have suggested that adequate resources such as education, behaviour modification and
drug therapy are essential components of successful smoking cessation programs
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(American Heart Association, 2005; Heart and Stroke Foundation, 2008; Mallin, 2002;
National Cancer Institute, 2006).
Despite knowledge of the physical and psychological stressors associated with
smoking cessation, it is a standard practice to impose strict and abrupt smoking cessation
restrictions upon patients who are hospitalized for the treatment of AMI. Such a practice
is problematic given that studies have suggested a correlation between clinical symptoms
of CAD and high levels of life stress (Ariyo et al., 2000; Spence, Barnett, Linden,
Ramsden, & Taenzer, 1999). Furthermore, anxiety and depression among newly
diagnosed AMI patients is common (Crowne, Runions, Ebbesen, Oldridge & Streiner,
1996; De Jong et al., 2005) and may later predict the occurrence of adverse cardiac
events (Carney, Freedland, Eisen, Rich, & Jaffe, 1995; Frasure-Smith, Lesperance, &
Talajic, 1993; Grace et al., 2005).
De Jong et al. (2005) suggested that 10 to 26 percent of hospitalized persons with
AMI are more anxious than those who have been diagnosed with a psychological
disorder. Moser and Dracup (1996) reported that individuals with higher states of anxiety
after AMI have a 4.9 times higher incidence of in-hospital complications, such as
reinfarction, acute ischemia, sustained ventricular tachycardia, ventricular fibrillation and
in-hospital death. In addition to its impact on the physiological outcomes of AMI
patients, psychological distress may also interfere with an individual's ability to return to
work (Lewin, 1995) and his or her ability to engage in necessary self-care behaviours and
lifestyle changes (Lawrence & Lawrence, 1987). In fact, smoking cessation is one
lifestyle change is impeded by psychological distress (Brown & Mumford, 1984). That is,
individuals who experience increased stress are less likely to succeed in quitting.
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Although there is empirical evidence to support the relationship between
smoking cessation and stress (Cohen & Lichtenstein, 1990; Parrot, 1992; VanderKaay &
Patterson, 2006), little is known about: (a) the impact of abrupt smoking cessation on the
stress levels of hospitalized AMI patients, and (b) whether stress resulting from abrupt
smoking cessation increases the physical complications experienced by these patients.
That is, to date, no studies have examined the psychological and physiological impact of
abrupt smoking cessation in hospitalized AMI patients. Such research may aid nurses in
minimizing the associated physiological and psychological stress, and in developing
interventions to improve coping during the initial stages of the AMI experience. In
addition, positive coping with smoking cessation during hospitalization may translate into
long-term smoking cessation, which may lead to reduction in morbidity and mortality
rates.
Purpose of the Study
The general purpose of this study is to develop a greater understanding of the
physiological and psychological stressors of hospitalized AMI patients who abruptly
cease smoking. Specifically, the proposed study will (a) compare the psychological
indicators of stress between smoking and non-smoking hospitalized AMI patients (b)
compare the outcomes of smoking and non-smoking patients with respect to differences
in length of stay, cardiac arrhythmia, re-infarction and arrhythmia; and (c) examine the
relationship between the psychological indicators of stress and patient outcomes
following AMI.
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Conceptual Framework
The Transactional Model of Stress and Coping
The Transactional Model of Stress and Coping is a theoretical framework for
evaluating how individuals cope with stressful events (Lazarus & Folkman, 1984).
According to this framework, stress and coping can impact the psychological well-being,
health behaviours, and the physical health of individuals. The theory further asserts that
appraisal processes impact emotional responses, and that coping strategies are utilized by
individuals in order to reduce negative emotions and maintain positive emotional
responses. Key assumptions of this framework will be examined in order to better
understand how coping efforts impact adaptation to stress. A modified version of the
model is presented in Figure 1 on the subsequent page. Only the concepts which support
the relationships being examined are included in the adapted model.
The Appraisal Process
When a person is faced with a stressor, the individual engages in both primary
appraisal and secondary appraisal (Lazarus & Folkman, 1984). Primary appraisal refers
to the individual's perception of an event as being potentially threatening to personal
well-being. When an individual suffers an AMI, he or she may or may not perceive the
situation to be threatening. This assessment is dependent upon a number of factors,
including the severity of the AMI symptoms and use of defense mechanisms, such as
denial. The individual's ability to assess options for coping, or control the outcomes or
emotions associated with the stressor is referred to as secondary appraisal. Thus,
secondary appraisal may include the ability of an AMI patient to assess available support
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Mediating Processes
Primary Appraisal
• Perceived susceptibility
• Perceived severity
• Motivational relevance
• Causal focus

Coping Efforts
• Problem management
• Emotional regulation
— •

Outcomes
Adaptation
• Emotional well-being
• Functional status
• Health behaviors

Stressor

Secondary Appraisal
• Perceived control over outcomes
• Perceived control over emotions
• Perceived elf-efficacy to change situation

Figure 1. Transactional Model of Stress and Coping, modified (Lazarus & Folkman, 1984)
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systems and verbalize the emotions concerning the impact of the event on work, family
and/or lifestyle. In the case of a smoker with AMI, the individual generally finds that
one of his or her usual coping strategies, smoking, is not an option in the hospital
environment.
The primary and secondary appraisal processes combine to determine the
emotional response of the individual. For example, stress in the AMI patient is mediated
by the individual's lack of ability to change the situation, and his/her perceived ability to
manage one's emotions or effectively cope with the situation. Thus, greater emotional
distress is expected in a patient who experiences a negative perception of coping options
and perceives AMI to be a threat to well-being.
Coping Efforts
According to Lazarus and Folkman (1984), the outcomes of the coping process
are influenced by coping efforts, which include both problem-focused strategies and
emotion-focused strategies. In order to alter or change a situation to one that is more
consistent with personal desires, an individual engages in cognitive efforts that are
problem-focused. Also known as problem management strategies, these problem-focused
efforts may include active problem solving and information seeking. Conversely,
emotion-focused efforts involve processes to minimize the stressful nature of the
situation. These efforts may involve redirecting attention away from the distressing
elements of the situation, or by re-interpreting the situation in a novel or more favourable
manner. According to Lazarus and Folkman, the problem-focused strategies which are
characterized as being positive, active and expressive, result in significantly higher levels
of functioning and psychological well-being. These authors further assert that emotion-
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focused coping strategies are used most often when the stressor is unchangeable.
Emotion-focused coping strategies may include efforts such as avoidance, denial, social
support, and venting of feelings.
Outcomes
An individual's adaptation to a stressor is measured in terms of coping outcomes
(Lazarus & Folkman, 1984). These outcomes are manifested following initial appraisal of
the situation (primary appraisal) and an assessment of available resources (secondary
appraisal). Both of these processes are influenced by emotion-focused and problemfocused coping efforts. Coping outcomes may be categorized as emotional well-being,
functional status and health behaviours. Lazarus and Folkman define functional status as
including concepts such as health status, physical limitations and disease progression.
For the purpose of this study, the impact of loss of usual coping strategies (i.e.
smoking) on the stress and adaptation of the individual will be examined. An illustrative
representation of the relationships among the concepts of interest is presented in Figure 2
on the subsequent page. Given the fact that individuals have reported smoking as a means
of coping or diverting attention from stressful situations (Bennett et al., 1999), this study
proposes that smoking can be considered an emotion-focused coping effort. Among
hospitalized AMI patients, smoking is not an available emotion-focused strategy, and
AMI is not a changeable stressor. Furthermore, when abrupt smoking cessation is
imposed upon an AMI patient, the symptoms of nicotine withdrawal represent additional
stressors. A patient's adaptation to the stress associated with the AMI and abrupt smoking
withdrawal is represented by coping outcomes. These outcomes include indicators of
emotional well-being, such as measures of mood and insomnia. In the AMI patient,
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AMI
(Stressor 1)

Coping Efforts
(Smoking Status)
Nicotine Withdrawal (Stressor 2)
vs. Non-withdrawal

Length of
Stay
Re-infarction
Arrhythmi

Ischemia

Figure 2. Study Application of the Transactional Model of Stress and Coping

11
functional status may be manifested through physical outcomes, such as length of stay,
angina, arrhythmia or re-infarction. Thus, when applied to this patient population, the
Transactional Model of Stress and Coping (Lazarus & Folkman, 1984) suggests that
smokers will experience greater distress than those who do not smoke. That is because,
unlike non-smokers, smokers are unable to utilize smoking as an emotion-focused coping
strategy. The model further predicts that there will be a difference in the measures of
functional status between smokers and non-smokers. In addition, the framework suggests
that the coping outcomes may interact with one another. That is, there is a relationship
between emotional well-being and functional status. Therefore, when applied to this
population, this study posits that there is a reciprocal relationship between measures of
mood and insomnia and functional status of the AMI patient, as measured by length of
stay, re-infarction, cardiac ischemia and arrhythmia. The relationship between these
concepts is depicted in Figure 2.
Research Questions
1. Is there a difference in the psychological well-being of smoking and nonsmoking AMI patients as measured by insomnia, tension/anxiety,
depression/dejection and anger/hostility, fatigue/inertia?
2. Is there a difference in the functional outcomes of smoking and non-smoking
AMI patients as measured by length of stay, arrhythmia, re-infarction and cardiac
ischemia?
3. Is there a correlation between the functional status and psychological well-being
of patients following AMI?
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Significance for Nursing
The issue of stress and coping among smokers has not been extensively studied in
the hospitalized AMI population. In fact, no known studies exist that have sought to
understand both the physiological and psychological outcomes of smoking cessation in
this population. Therefore, new knowledge may provide significant implications for both
research and nursing practice. Recognition of the causes and deleterious effects of
psychological distress in AMI patients is essential for the achievement of positive
psychological and physiological outcomes. As compared to other health care providers,
nurses are in a particularly unique position to assess and implement strategies to decrease
stress and enhance positive coping patterns among AMI patients. Given that anxiety,
depression and coping patterns are amenable to nursing intervention (Conn, Taylor, &
Wiman, 1991), this study may suggest salient interventions for enhancing both the
physiological and psychological outcomes of hospitalized AMI patients. Such
interventions are anticipated to bring about subsequent reduction in morbidity and
mortality, and improvement in post-AMI quality of life. Furthermore, dissemination of
the knowledge of the potential negative psychological and physiological outcomes of
abrupt nicotine withdrawal during hospitalization following AMI may serve as an
impetus for individuals at risk for AMI to engage in smoking cessation prior to the
occurrence of negative cardiac events. Consequently, this behaviour change would reflect
an important means of promoting primary prevention for cardiovascular disease in at risk
populations.
The findings of this study can be utilized to conduct future research studies in this
population. Intervention studies utilizing validated smoking cessation strategies may

13
demonstrate improved coping and successful reductions in both stress and cardiac
outcomes in hospitalized AMI patients. Furthermore, successful coping with smoking
cessation during hospitalization may translate into long-term smoking cessation, which
may lead to subsequent reduction in associated morbidity and mortality rates.
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CHAPTER II
REVIEW OF THE LITERATURE
Search Strategy
Research findings presented in this literature review were obtained through a
systematic review using five electronic databases: Proquest, Medline, Pubmed, the
Cochrane Database of Systematic Reviews and the Cumulative Index of Nursing and
Allied Health Literature (CINAHL). In addition, published theses and dissertations were
searched. Keywords used in the search process were stress, coping, anxiety, depression,
smoking and hospitalization. These keywords systematically searched in varying
combinations with the keywords: acute myocardial infarction or heart attack. The
keywords were present in the title, abstract, or the text of the article. This approach
yielded 15 published peer reviewed articles and one doctoral dissertation. Bibliographies
of the research studies obtained from the search process were further scanned for
potentially relevant articles. This resulted in 8 articles. An e-mail address of one author
obtained via an internet search was utilized to obtain one additional article. Thus, the
search process yielded a total of 24 articles and one doctoral dissertation.
The Review
The Physiological and Psychological Impact of Nicotine Withdrawal
A number of studies have suggested that cessation of nicotine consumption
impacts the smoker and produces withdrawal symptoms. In cardiac patients, smoking
cessation is associated with improved cardiac outcomes (American Heart Association,
2005; Dalai et al, 2004; Wilson et al., 2000). However, abrupt smoking cessation during
the initial hospitalization phase of AMI could potentially lead to physical and
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psychological stress that could impede these outcomes. The following section
summarizes findings specific to this issue.
In a prospective study of 554 unaided quitters, tobacco withdrawal was assessed
in order to better understand the nature of withdrawal (Gritz et al., 1991). Data were
collected at baseline, 1 week, 1 month, 3 months, 6 months and 12 months. Participants
completed a questionnaire that solicited information concerning the degree of nicotine
dependence and nature and severity of withdrawal symptoms. The vast majority of
abstainers reported experiencing one or more withdrawal symptoms at day 1 (87.0%),
day 2 (90.3%) and week 1 (97.5%). Specifically, symptoms of anxiety (44%, 49%, 42%,
respectively for days 1,2 and at week 1) and restlessness (47%, 55%, 47%, respectively
for days 1,2 and week 1) were reported by smokers who remained abstinent. Repeated
measures analyses revealed that both the number of symptoms (F = 5.58, p < .01) and the
severity of symptoms (F = 22.94, p < .01) peaked on day 2.
Hughes (1992) conducted a longitudinal analysis of self-reported and observerrated signs and symptoms of nicotine withdrawal where 178 respondents who abstained
from smoking at two, seven, 14 and 30 day follow-ups were compared to control groups
of 56 long-term smokers, 67 current smokers and 61 individuals with no smoking history.
Subjects completed self-report questionnaires that solicited information regarding the
symptoms and behaviours associated with nicotine withdrawal. Observers were recruited
to periodically rate the subject on similar indicators. Scores for anxiety, hunger,
irritability, decreased heart rate, depression, difficulty concentrating and restlessness were
greater at day 30 than pre-cessation among subjects who remained abstinent. Post hoc
tests confirmed that at day two post-cessation, anxiety, difficulty concentrating,
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irritability, restlessness, decreased heart rate and hunger differed significantly from
baseline. At day seven post-cessation, increase in cigarette craving was associated with
an increase in mood symptoms (r = .34) and depression (r =.50), but nop values were
provided. Furthermore, increases in depression were correlated with increases in
irritability (r = .41) and anxiety (r = .45).
VanderKaay and Patterson (2006) assessed the effects of nicotine and nicotine
withdrawal on blood pressure and cardiac function during psychological stress. They
subjected 46 smokers to stressors (i.e., an arithmetic task and cold), then tested their
cardiovascular reactivity. Each participant was tested twice, once while wearing a 21 mg
nicotine patch, and once while wearing a placebo patch. When subjected to the arithmetic
task during nicotine withdrawal, participants demonstrated greater heart rate reactivity (t
= 2.18, p < .04), increased systolic blood pressure (t = 2.19, p < .04), increases in anxiety
(t = 2.30,p < .03) and anger (t = 2.38,/? < .03). Similarly, exposure to cold, while
experiencing nicotine withdrawal, resulted in greater heart rate variability (t = 4.77, p <
.0001) and increased diastolic blood pressure (t = 3.77,/? < .01).
Tsuda, Steptoe, West, Fieldman and Kirschbaum (1996) examined the impact of
smoking and temporary withdrawal on the mood and behavioural performance of 49
individuals who were assigned to three groups: non-smokers (« = 16), regular smokers
randomized to overnight abstinence (n = 14) and regular smokers who smoked 30
minutes prior to testing (n = 19). Participants were administered a computerized problemsolving task based on a series of progressively more difficult matrices. Analysis of
variance (ANOVA) revealed that the three groups differed in terms of the percentage of
problems they correctly solved ( F = 3.13, p = .05), such that abstainers averaged 91.7%,
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while non-smokers averaged 94.3% and recent smokers averaged 96.1%. The authors
reported impaired behavioral performance and symptoms of nicotine craving among the
abstinent group (p < .01). Furthermore, during the three points of data collection,
measures of tension and anger were lower in non-smokers than either of the two smoker
groups (p < .01).
In a retrospective study, Rea et al. (2002) examined the association between
smoking status and risk for recurrent coronary events in patients discharged from hospital
following AMI. A sample of 2619 subjects who survived an initial AMI was recruited
from a health maintenance organization in the United States. Following assessment of
smoking status, participants were classified as non-smokers (persons with no smoking
history), former smokers (persons who had quit prior to the AMI), quitters (persons who
were smoking at the time of the cardiac event and quit after the infarction) and active
smokers (persons who smoked at the time of the cardiac event and continued smoking
following the AMI). The endpoint of interest was recurrent AMI or coronary death.
Statistical analysis revealed that those who quit smoking after the event, but were
smoking at the time of the AMI, had a higher hazard ratio than non-smokers (RR = 1.43,
95%

CI= 1.07-1.93) and those who continued to smoke (RR= 1.51, 95% CI= 1.10-2.07).

These findings are highly significant to the second research question, which examined
how smoking status impacts patient outcomes. It may follow that the stress imposed by
abrupt nicotine withdrawal increases the risk for recurrent coronary events, such as reinfarction and cardiac death following AMI.
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The Relationship between Stress and AMI
A number of investigators suggested that AMI patients perceived stress to be a
significant cause of AMI (Clark, 2003; Condon & McCarthy, 2006; Fukuoka et al., 2004;
King, 2002; McKibbin & Wilson, 2001). Among smokers, this is problematic given that
the stress, which is perceived to have contributed to the AMI, is compounded by the
additional stress of abrupt nicotine withdrawal. The following text discusses research
findings related to the physiological and psychological impact of stress following AMI
on: (a) cardiac function and outcomes, such as acute ischemia, re-infarction, arrhythmia
and death (b) psychological distress and coping; and (c) the subsequent ability to
implement self-care activities.
The Physiological and Psychological Impact ofStress
A review of the literature provides evidence that stress following AMI impacts
cardiac function and outcomes (i.e., length of stay in CCU, ischemia, re-infarction),
psychological distress and coping and the ability to implement self-care activities,
including smoking cessation. The results of these studies are summarized in the following
text.
Cardiac function and outcomes. Bacon et al. (2006) investigated the effects of
mental stress on blood pressure, heart rate and cardiac output on a sample of 72 cardiac
patients and found that stress produced significant increases in systolic blood pressure,
diastolic blood pressure, heart rate and cardiac output (F = 55.75, F = 21.37, F = 104.37,
F ~ 54.96, respectively, all/? < .001). The validity and reliability of this study may be
questioned given the high refusal rate (59%) among those invited to participate.
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Moser and Dracup (1996) conducted a prospective study to examine the
association between early onset anxiety among AMI patients and subsequent in-hospital
complications. The study involved multiple cardiovascular centres who were involved in
the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded
Coronary Arteries (GUSTO) trial. In total, 86 confirmed AMI patients were recruited.
The Brief Symptom Inventory (Derogatis, 1975) was utilized to measure the
psychological distress of the participants. The outcome of interest was the occurrence of
cardiac complications including acute ischemia, re-infarction, sustained ventricular
tachycardia, ventricular fibrillation or in-hospital death. Complications were observed in
19.6% of patients who reported increased anxiety levels as compared to 6% of
individuals who reported lower levels of anxiety (p = .001). When patients with higher
anxiety were compared to those with lower anxiety, chi square analysis suggested that
ischemia (11% vs 3%,p = .02), re-infarction (4.7% vs 0.0%,p = .04) and ventricular
fibrillation (7.8% vs \.5%,p = .03) were significantly higher among patients with high
anxiety. Multiple logistic regression suggested that anxiety remained a significant
predictor of cardiac complications during hospitalization (OR = 4.9, 95% CI = 2.1-12.2,/?
= .003).
In a 6 year cohort study, Ariyo et al. (2000) examined the association of
depression with coronary heart disease and all-cause mortality in older American adults
(mean age = 72 years). Measures of depression were gathered at baseline and annually
from a sample of 4493 subjects for 6 years or until the incidence of a cardiac-related
event or death. The findings suggested that every five point increase in mean depression
score was associated with a 15% increased risk of developing CHD in both men and
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women (p = .006). The hazard ratio for mortality was 1.16 (p = .006). Multivariate
analysis further revealed that individuals with higher baseline depression scores had a
60% higher risk for mortality (p = .012) compared to those with the lowest mean baseline
depression scores. After controlling for confounding variables, baseline depression was
also a significant predictor of CHD (hazard ratio =\A,p = .032) and death (hazard ratio
= 1.6,/? = 0.012).
Grace et al. (2005) conducted a longitudinal observational study to examine the
relationship between depression during hospitalization for a cardiac event and subsequent
all-cause mortality in a sample of 910 patients who were hospitalized with an acute
coronary syndrome. Of this initial cohort, 856 were matched to the Canadian Institute of
Health Information Discharge Abstract Database. Following this process, 750 subjects
were determined to have a valid history of depression responses. Two hundred thirty-five
respondents (31.3%) reported elevated depression scores during hospitalization. An
additional 105 participants reported symptoms of depression (14.0%). The findings
further revealed that 115 participants (15.3%) died within 5 years of hospitalization. After
adjusting for confounders, the hazards ratios suggested that depressive symptomatology
during hospitalization for acute coronary syndromes significantly (all/? < .001) predicted
mortality at 2 years (1.90), 3 years (1.61), 4 years (1.76), and 5 years (1.53).
Frasure-Smith et al. (1993) conducted a prospective study to examine the
association between major depression in patients hospitalized following AMI and cardiac
mortality in the first 6 months following discharge. The authors recruited 222 subjects
from a Quebec cardiac care facility over an 11 month period. The sample was 78% male.
In addition to demographic data and smoking status, information regarding depression

21
was gathered using a modified version of the National Institute of Mental Health
Diagnostic Interview Schedule (DIS). The unadjusted results showed that in the six
month period following discharge, 12 patients died of cardiac causes and that depression
was as a significant predictor of mortality (RR = 5.1A,95% CI = 4.6-6.87,/? = .0006). After
controlling for confounding variables such as left ventricular dysfunction and previous
AMI, the aforementioned association remained significant (adjusted hazard ratio = 4.29,
95%

C/= 3.14-5.44,/? = .013).
Subsequent to the above study, Frasure-Smith, Lesperance, Juneau, Talajic and

Bourassa (1999) examined the issue of gender differences and the impact of depression
on one-year mortality following hospitalization for AMI. The researchers performed
secondary analysis on data gathered from previous studies that measured depression
symptoms during hospitalization using the Beck Depression Inventory (BDI) (Beck,
Ward, Mendelson, Mock, & Erbaugh, 1961). Data from 896 subjects suggested that
47.0% of women (p < .001) and 25.6% of men (p < .001) had BDI scores > 10,
indicating symptoms of mild to moderate depression (women's mean = 11.3 + 9.3 and
men's mean = 7.1 + 7.1). Furthermore, 8.3% of depressed women and 7.0% of depressed
men died of cardiac causes (compared to 2.7% and 2.4% of non-depressed women and
men, respectively). Increased BDI scores significantly predicted cardiac mortality in both
women (OR = 3.29, 95% CI= 1.02-10.59) and men (OR = 3.05, 95% CI= 1.29-7.17). After
controlling for other predictive factors, depression remained an independent predictor of
cardiac mortality (OR = 3.66,95% CI = 1.68-7.99).
Psychological distress and coping. Mayou et al. (2000) examined the association
of anxiety and depression following AMI with the incidence of subsequent psychological
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distress on a sample of 344 subjects who completed self-report questionnaires during
hospitalization, and at three and 12 month intervals. Of this sample, 73% were male. The
results suggested that more hospitalized distressed subjects were smokers (55% vs. 29%,
p < .001). The authors also reported an association between distress during
hospitalization and a longer hospital stay, although no supporting data analysis results
were provided. Patients who reported higher rates of anxiety and depression during
hospitalization continued to report higher mean scores of distress at three months and at
one year, as compared to those who were not distressed during hospitalization (p < .05).
Patients who experienced psychological distress during hospitalization had higher anxiety
and depression scores at baseline, three months and one year (means = 14,10, and 10
respectively) compared to those who were not distressed (means = 6 for all time frames).
Lowe, Norman, and Bennett (2000) conducted a longitudinal study to examine the
relationships among coping, emotions and perceived health among initial AMI patients in
the first six months following the cardiac event. Use of coping strategies, emotion
outcomes and perceived health were measured using the COPE instrument (Carver,
Scheier, & Weintraub, 1989), the Global Mood Scale (Denollet, 1993), the short form of
the Spielberger Stait-Trait Anxiety Inventory (Spielberger, Gorsuch, Lushene, Vagg, &
Jacobs, 1983) and the Health Complaints Scale (Denollet, 1994) respectively. During
hospitalization, anxiety was positively correlated with avoidant-focused coping (r = .22,p
< .05) and negatively correlated with acceptance-focused coping (r = -.22, p < .05).
Multiple regression confirmed these findings. The coping factors explained 16% of the
variance in anxiety (F = 6.18, p < .001).
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In a cross-sectional study, Chalfont and Bennett (1999) explored the relationship
between hardiness and mood following AMI. Three to 12 months following hospital
discharge, 59 subjects (all men) completed surveys with measures related to anxiety,
depression and hardiness. The Hospital Anxiety and Depression Scale (Zigmond &
Snaith, 1983) measured anxiety and depression, while the Personal Views Survey (Maddi
& Khoshaba, 1994) was utilized as a measure of hardiness. The data suggested that
higher depression and anxiety scores were significantly associated with lower perceived
feelings of control (r = -.036, p < .01; r = -.49, p < .00, respectively).
Among post-myocardial infarction patients in the United Kingdom, measures of
mood were predicted by coping strategies; cigarette smoking was cited as a coping
strategy to reduce stress (Bennett et al., 1999). Thirty-seven participants described
behaviours prior to hospitalization, during hospitalization and three months following
discharge. During hospitalization, high levels of anxiety were correlated with the
following coping strategies: distraction (r = 0.290, p< 0.05), not seeking social support (r
= 0.289,/? < 0.05) and disengagement (r - 0.326,p < 0.01). Depression scores in hospital
were correlated with the emotion-focused strategies of denial (r = 0.492,/? < 0.01),
venting of emotions (r = 0.348,/? < 0.05) and disengagement (r = 0.456,/? < 0.01). Three
months following AMI, smoking was negatively correlated with seeking social support (r
= -0.332,/? < 0.05). Hierarchical regression revealed that this last association remained
after controlling for confounding variables (R2 = 0.319, p = -0.565, t = -2.742,p < 0.05).
Ability to engage in self-care behaviours. Rose, Conn, and Rodeman (1994)
examined the relationship between anxiety during hospitalization for AMI and self-care
activities, including smoking cessation. Three months after hospitalization, 62 male AMI
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patients (N= 39) completed the State-Trait Anxiety Inventory Test (Spielberger et al.,
1983) and the Health Behavior Scale (Miller, Wikoff, Garrett, McMahon, & Smith,
1990). The results suggested that individuals who had a higher state of anxiety during the
hospitalization period were more likely to report continued smoking behaviours three
months after their AMI (r = -.40, p = .01).
Conn et al. (1991) examined the relationship between anxiety, depression, quality
of life, and performance of suggested self-care behaviours among 94 older AMI
survivors. Following multiple regression analysis, depression predicted quality of life (ft
= -.70, p = .001), and depression was associated with engagement in smoking {fi = -.54, p
= .03).
Stewart et al. (2000) provided a qualitative description of the stressors, coping
strategies and social support experienced by AMI survivors (n = 14) and their spouses (n
= 14). The data suggested that stressors included both the emotional impact of the event
and lifestyle changes associated with the event. Emotional responses included fear,
frustration, irritability, depression and feelings of being overwhelmed. Smoking, as a
lifestyle change, was a stressor because it was often externally imposed upon the patient
and was a source of conflict for AMI survivors and their spouses. Patients used emotionfocused, problem-focused and relationship-focused strategies to cope with the AMI
experience. Examples of these strategies included denial, informational support and
active engagement through mutual problem solving, respectively.
Shiffman (1982) conducted a cross-sectional study of ex-smokers who were
experiencing a crisis related to relapse in smoking. They examined the coping process in
avoiding relapse and the factors that influenced relapse episodes among ex-smokers.
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Responses related to a series of open-ended questions revealed that 52% of relapses were
precipitated by negative affect (i.e., anxiety, frustration and depression) or stress.
Negative affect was perceived by depressed respondents as the precipitating source of the
crisis (x2= 4.40, p<. 05).
Smoking Status and Stress
Utilizing a cross-sectional, descriptive design, Kuhn (1996) examined three
domains of psychosocial functioning that distinguished between smokers, ex-smokers
and non-smokers in hospitalized AMI patients. These domains were: (a) perceived and
objective indices of health behaviour, (b) personality and psychopathology; and (c) social
adjustment. This represents the only known study which has examined the direct
relationship between smoking status and the psychological stress. A convenience sample
of 40 patients with a confirmed diagnosis of AMI was recruited from the Ottawa General
Hospital. Patients were classified according to smoking status. Depression was measured
using the Brief Symptom Inventory (Derogatis, 1975). Following a one-way repeated
measures ANCOVA, non-smokers were found to have higher depressive
symptomatology scores than ex-smokers and smokers (F = 3.84,/? < .05).
This study's findings must be interpreted with caution due to two statistical
limitations. First, sample size (N= 40) might have compromised the statistical power of
the study. Second, ANCOVA is not able to detect differences between groups on multiple
dimensions. Furthermore, this study was limited by data collection procedures that
occurred over an extended period from hospitalization to post-discharge, in which case,
control over smoking status was not maintained. Finally, time of data collection was not
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consistent with peak withdrawal, which occurs in the first two days following smoking
cessation (Gritz et al., 1991; Hughes, 1992).
Summary of the Literature Review
Although very little is known about the relationship between the impact of
smoking cessation on the stress and physical outcomes of AMI patients, the critical
appraisal of the literature provides persuasive support for this study. It has been reported
that AMI is a significant cause of stress (Fleury & Moore, 1999; Stewart et al., 2000) and
that stress is an untoward condition in individuals with coronary heart disease (Moser &
Dracup, 1996). Several authors reported stress as a perceived cause of AMI (Clark, 2003;
Condon & McCarthy, 2006; Fukuoka et al. 2004; King, 2002; McKibbin & Wilson,
2001). This is problematic given that abrupt smoking withdrawal represents additional
psychological distress, including anxiety, depression and insomnia (Gritz et al., 1991;
Hughes, 1992; Tsuda et al., 1996; VanderKaay & Patterson, 2006). Therefore, smokers
may experience increased stress, thus further magnifying the actual and perceived stress
response to the AMI. This relationship is concerning given that six quantitative studies
reported that mood disturbances, such as anxiety and depression were associated with
poorer physiological outcomes (Ariyo et al., 2000; Bacon et al., 2006; Grace at al., 2005;
Frasure-Smith et al, 1993; Frasure-Smith et al, 1999; Moser & Dracup). Specifically,
mood disturbance was associated with in-hospital complications in one study (Moser &
Dracup) and in mortality in five studies (Ariyo et al.; Frasure-Smith et al., 1993; FrasureSmith etal., 1999).
It is not known if the psychological indicators of stress differ between nonsmokers and those who are forced to quit smoking during the early phase of recovery
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following AMI. More specifically, it is not clear if the stress of smoking withdrawal has
an additive effect on the stress of AMI, thus leading to higher stress levels among
smokers as compared to non-smokers. The aforementioned literature review revealed
only one study that examined the relationship between smoking status and depression
during hospitalization for AMI (Kuhn, 1996). Although this study suggested that smokers
had lower depression scores than non-smokers, as previously reported, this study was
limited by several factors including: (a) sample size, (b) statistical procedures; and (c)
data collection procedures.
The direct impact of abrupt smoking withdrawal on the physical outcomes
following AMI is not known. Although the literature suggests an indirect relationship
between stress and physical outcomes following AMI (Ariyo et al., 2000; Bacon et al.,
2006; Grace at al, 2005; Frasure-Smith et al., 1993; Frasure-Smith et al, 1999; Moser &
Dracup, 1996), a direct relationship has not been empirically measured. One study
reported a relationship between psychological distress during hospitalization and a longer
hospital stay, although no supporting data analysis results were provided (Mayou et al.,
2000).
The literature concerning psychological coping and AMI is vast, as is the
relationship between smoking and psychological distress. However, there are no studies
that have thoroughly examined the relationship between both of these issues. In addition,
much of the literature related to stress and AMI to date has been conducted in male
populations (Bacon et al., 2005; Chalfont & Bennett, 1999; Condon & McCarthy, 2005;
Grace et al, 2005; Frasure-Smith et al., 1993; Fukuoka et al., 2004; Lowe et al., 2000;
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Mayou et al., 2000; Rose et al., 1994). As a result, the generalizability of the findings of
these studies may be limited.
Furthermore, several authors reported that psychological distress during
hospitalization was associated with subsequent maladaptive coping and negative mood
states (Bennett et al., 1999; Chalfont & Bennett, 1999; Lowe et al, 2000; Mayou et al.,
2000). An additional two studies reported that symptoms of psychological stress were
associated with continued smoking behaviours (Conn et al., 1991; Rose et al., 1994).
These findings suggest that stress may impact successful cardiac rehabilitation and postAMI quality of life. Hence, this study provides a novel approach to a significant health
issue, which may suggest potential implications for nursing research and practice in both
the immediate and rehabilitative period following AMI.
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CHAPTER III
METHODS
This chapter discusses the research design, setting and sample, conceptual and
operational definitions, inclusion criteria and procedures for protection of human
subjects.
Research Design
This study employed a descriptive, cross-sectional design. The psychological
impact of smoking cessation among AMI patients was measured via self-report
questionnaire. Survey packages were completed by patients in the Coronary Care Unit
(CCU) on day two following admission to the hospital with a diagnosis of AMI. In order
to examine the impact of abrupt smoking cessation on the functional outcomes of the
study participants, retrospective chart reviews of participant health records were
conducted following discharge of each subject from the hospital. The research questions
and hypotheses were tested via univariate and multivariate analyses, specifically t-tests,
Chi-square and multivariate analysis of covariance.
Setting and Sample
Setting
Study participants were recruited from two local hospitals: (a) Hotel Dieu-Grace
Hospital in Windsor, Ontario, and (b) Windsor Regional Hospital in Windsor, Ontario.
Given that only 14 cases were enrolled after four months, ethics approval was sought to
add a third site to the study. Approval was granted, and data collection subsequently
began at Chatham-Kent Health Alliance in Chatham, Ontario. The CCU's at each of the
two Windsor hospitals were nine-bed units, thus providing a total of 18 beds which were
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available for patient recruitment. The CCU at Chatham-Kent Health Alliance was a 10
bed unit. Hence, a total of 28 beds were available for recruitment of study participants.
The CCU at Hotel Dieu Grace Hospital consisted primarily of private rooms, therefore
providing sufficient privacy and confidentiality for recruitment. A combination of private
and semi-private accommodations comprised the design of the CCU's at Windsor
Regional Hospital and Chatham-Kent Health Alliance. Given that participants were not
asked to verbalize their responses, the presence of curtains was considered sufficient to
maintain the privacy and confidentiality of responses.
Sample
A non-probability convenience sample was utilized to obtain subjects from the
three research sites. Inclusion criteria was as follows: (a) a clinical diagnosis of AMI
documented by elevated cardiac markers in the hospital record; (b) 18 years or older; (c)
clinically stable; and (d) able to read and understand English. Patients were excluded
from the study if they: (a) had unstable vital signs; (b) were mechanically ventilated; (c)
required vasoactive medications other than nitroglycerin; (d) had a history of psychiatric
diagnosis (anxiety disorder, depression or other psychiatric illness); and/or (d) engaged in
smoking between admission and data collection, or were involved in a smoking cessation
program prior to admission.
Given that the findings of this research study are reported as a pilot study, 60
participants, males and females, were recruited over a period of 9 months. Three cases,
with incomplete data representing greater than 20% of the survey, were not included in
data analysis. In total, 57 cases were entered into the data analysis, 29 of whom were
actively smoking prior to hospitalization.
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Variable Definitions
AMI and Smoking Status
AMI is defined by a blockage in a heart artery, which results in necrosis of the
heart muscle (Glanze, Anderson, & Anderson, 1992). Diagnosis of AMI was confirmed
based upon documentation of elevated cardiac markers in the patient's medical record.
Given that the physiological and psychological symptoms of smoking withdrawal reach
precessation levels by 30 days postcessation (Hughes, 1992), a current smoker was
defined as an individual who reported using at least one nicotine product (cigarette, cigar,
pipe or chewing tobacco) per day at the time of hospital admission or within one month
prior to admission. A non-smoker was defined as an individual who had never smoked,
never used a nicotine product, or who had quit at least one month prior to hospital
admission. Smoking status was determined via self-report.
Psychological Indicators of Stress
Stress is defined as an individual's cognitive interpretation of potentially stressful
events (Lazarus & Folkman, 1984). It involves a relationship between the demands of the
environment and the ability to cope with these demands. Anxiety and depression are
manifestations of stress. Anxiety is defined as a multidimensional somatic, experiential,
and interpersonal phenomenon and may be manifested as a feeling of worry, upset,
uncertainty, uneasiness, apprehension, or dread (Glanze et al., 1992). It is manifested by
psychomotor manifestations of heightened musculoskeletal tension which may not be
overtly observable (McNair, Lorr, & Droppleman, 1992). Depression is conceptually
defined as sadness, guilt, emotional isolation, futility and feelings of personal
worthlessness (McNair et al.). Furthermore, McNair et al. consider anger and fatigue to
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represent symptoms of mood disturbance. Glanze et al. define anger as "a feeling of
displeasure, rage, upset, or hostility" (p. 42) and fatigue as "a state of exhaustion or a loss
of strength or endurance" (p. 312).
In this study, four subscales of the Profile of Mood States Brief Version (POMS,
McNair et al., 1992) were considered to reflect negative mood dimensions, which may be
associated with symptoms of nicotine withdrawal. These measures of mood were: (a)
tension/anxiety; (b) depression/dejection; (c) anger/hostility; and (d) fatigue/inertia. In the
analysis, these dimensions were considered individual measures of mood. The POMS
(Appendix A) has been used with many patient populations to assess transient, distinct
mood states, including those with myocardial infarction (Oldridge, Streiner, Hoffman, &
Guyatt, 1994). The short version is recommended for use when there are patient
limitations such as fatigue, (Shacham, 1983) as can occur following AMI. The brief
version of the POMS consists of 30 single-word items that measure six dimensions of
mood. Responses were rated on a 5-point likert type scale with responses ranging from 0
{not at all) to 4 {extremely). A total score was computed for each measure of mood, with
higher scores reflecting higher levels of the symptom severity. The POMS Brief takes
five minutes to complete.
Test-retest reliability coefficients have ranged from r = 0.65 to r = 0.74 and are
considered appropriate for assessing emotional states that are transient and expected to
respond to clinical interventions (Peterson & Headen, 1984). McNair et al. (1971)
reported internal consistency reliabilities at .90 to .92 for anxiety and .95 for depression
and adequate convergent and divergent validity of the subscales of the POMS. In a study
with cancer patients, Baker et al. (2002) evaluated the psychometric properties of the
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POMS Brief. The internal consistency reliability for the subscales of interest in Baker and
colleagues' study ranged from .78 to .91. In the same study, correlations of the short form
of the POMS with other psychosocial measures (the Centre for Epidemiological Studiesdepression scale (CES-D), the Self-rated Karnofsky Performance scale, the Medical
Outcomes Study (MOS SF-20), and the Bradburn Positive and Negative Affect Scales)
were examined. The POMS subscale of depression/dejection correlated most highly with
the CES-D (0.63) and the negative affect subscales of the Bradburn scale (0.52). The
POMS subscale of fatigue/inertia correlated with the CES-D (0.34) and with the negative
affect scale (0.34). Similarly, the POMS subscale of tension/anxiety correlated with the
CES-D (0.49) and with the negative affect scale (0.56). The subscales of
depression/dejection correlated negatively (-0.20) with the MOS SF-20 physical
functioning scale and the Self-rated Karnofsky Performance scale. The POMS
fatigue/inertia subscale correlated negatively with these two psychosocial measures (0.42;
0.40, respectively) as did the subscale of tension/anxiety (0.08; 0.08, respectively). This
pattern of correlations provided support for the convergent and divergent validity of the
subscales of the brief version of the POMS.
In order to confirm the reliability and validity of the individual measures of mood
with the population of interest, reliability statistics and factor analysis were conducted on
the data. Cronbach's alpha scores ranged from .75 (depression/dejection) to .94
(fatigue/inertia). Factor analysis revealed good to excellent loadings on each of the
measures of mood (Table 1).
Insomnia is defined as a chronic inability to sleep or to remain asleep through the
night and can be caused by a variety of physical and psychological factors (Glanze et al.,

34
Table 1
Psychometric Testing of the Psychological Indicators of Stress
Mood scale/Items

Factor loadings

Anxiety scale

Chronbach's a
.855*

Nervous

.842

Anxious

.828

Tense

.799

Uneasy

.779

Shaky

.732

Depression

.754*

Lonely

.810

Gloomy

.771

Discouraged

.690

Unworthy

.674

Sad

.598

Anger

.857*

Bad-tempered

.864

Grouchy

.836

Angry

.833

Annoyed

.764

Furious

.689
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Mood Scale/Items

Factor loadings

Chronbach's a
.936*

Fatigue scale
Fatigued

.920

Exhausted

.913

Weary

.895

Sluggish

.887

Worn out

.847
.922**

Insomnia scale
Difficulty staying asleep

.902

Interference of sleep problems

. 890

Extent of worry about sleep problems

. 841

Difficulty falling asleep

. 821

Satisfied with sleep

.808

Problem waking too early

.806

Noticeability of sleep problems to others .703
denotes reliability of dimensions of POMS Brief
denotes reliability of the ISI
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1992). In this study, insomnia was measured utilizing the Insomnia Severity Index (ISI,
Morin, 1993). The ISI is a brief and valid tool, which is sensitive to discrete change, and
is designed to assess the patient's perception of his/her insomnia (Bastien, Valliers, &
Morin, 2001). The ISI is comprised of seven items that assess the severity of sleep onset
and sleep maintenance difficulties, satisfaction with current sleep pattern, interference
with daily functioning, noticeability of impairment related to sleep problems, and the
degree of stress caused by the sleep problem. Each item is rated on afive-pointlikert type
scale and the total score rangesfrom0 to 28, with higher scores implying severe levels of
insomnia. Insomnia is categorized as non-clinically significant insomnia (score = 0-7),
subthreshold insomnia (score = 8-14), moderately severe insomnia (score = 15-21), and
severe insomnia (score = 22-28). Bastien et al. (2001) reported adequate internal
consistency (r = 0.74). Concurrent validity of the ISI was assessed with Pearson's
correlation coefficients by correlating the ISI scores with the sleep efficiency variables
obtained from the sleep diary and polysomnography that were also used in the study. The
size of the correlations between the ISI insomnia categories (subthreshold, moderately
severe, and severe) and sleep efficiency obtained with the sleep diary rangedfrom0.32 to
0.55 at baseline andfrom0.50 to 0.91 at post-test (p <_0.05). Correlations of the ISI
scores with the sleep efficiency obtained with polysomnography ranged from 0.07 to 0.45
at pre-test andfrom0.23 to 0.45 (p < 0.05) at post-test.
Table 1 summarizes the psychometric testing of the ISI. Reliability of the
instrument was demonstrated through a Chronbach's alpha of .92. In addition, factor
analysis revealed good to excellent loadings of all items in the instrument (.70 to .90).
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Physiological Outcomes
The physiological outcomes of interest in this study were length of stay, acute
cardiac ischemia, cardiac arrhythmia and re-infarction. For the purpose of this study,
length of stay was defined as the length of CCU hospitalization and was measured in
terms of the number of days from admission to discharge from the CCU. Acute cardiac
ischemia refers to inadequate blood supply to the myocardium, which is marked by pain
and organ dysfunction (Glanze et al., 1992). Acute ischemia was evidenced by frequency
of new onset chest pain for which nitroglycerin or morphine is administered. Measures of
this variable were determined through documentation of the administration of either
medication in the patient record. Arrhythmia is defined as "any change in the normal
pattern of the heart beat" (Glanze et al, p. 60). Cardiac arrhythmias of interest to this
study were: (a) sustained ventricular tachycardia requiring pharmacologic or electrical
intervention, or (b) ventricular fibrillation. Sustained ventricular tachycardia is defined as
a persistent run of premature ventricular contractions with a rate between 120 to 200
beats per minute (Thaler, 1995). Ventricular fibrillation is marked by complete lack of a
regular heart beat generating no cardiac output, and EKG tracings which reveal no true
QRS complexes (Thaler, 1995). Cardiac arrhythmia was operationalized in terms of the
frequency of events, as documented in the patient record. Re-infarction is conceptually
defined in terms of whether the patient experienced an extension of the existing AMI or
new cardiac necrosis due to a secondary event. A patient was considered to have a reinfarction if documentation in the medical chart confirmed this occurrence.
Data Collection
Prior to data collection, approval of the study protocol was obtained from the
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Research Ethics Boards of the University of Windsor, Hotel Dieu-Grace Hospital,
Windsor Regional Hospital and Chatham-Kent Health Alliance. In order to explain the
study and methodology, the investigator discussed the study with the unit managers and
staff of the CCU's prior to the start of this study. Two registered nurses (one employed at
Windsor Regional Hospital and one employed at Chatham-Kent Health Alliance) and one
nursing student from the University of Windsor were hired and trained to assist with data
collection. Given that research has suggested that the number and severity of withdrawal
symptoms peaks on day two (Gritz et al, 1991), data were collected by the researcher
and/or trained research assistants on the second day following admission to the CCU.
Guidelines for recruitment of subjects is described in Appendix C. Patients who met the
inclusion criteria were approached by the researcher or research assistant, given a full
verbal and written explanation of the study, and were invited to participate. All
individuals who agreed to participate in the study provided informed consent, thus
indicating their willingness to participate in the study. Granting permission to review
medical charts was provided to the researcher by each subject. The subjects' charts were
reviewed for documentation of data such as, anginal episodes, arrhythmia and reinfarction (Appendix A). This data was coded to correspond with participant self-reported
data. In order to verify clarity of response items and length of time needed for
completion, pre-test of the survey was conducted with a sample of five individuals who
met the inclusion criteria. As no amendments were required to the protocol, this pre-test
data was included in the analysis.
The survey package consisted of a letter from the investigator, a demographic
data questionnaire, the POMS Brief and the ISI (Appendix A). The assessment
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package was given to the participants on day 2 after admission to the CCU. Upon
consenting to participate in the study, the investigator provided participants with verbal
instructions concerning the completion of the survey. Participants were also provided the
opportunity to review the questionnaires and ask questions. The researcher or research
assistant was not present during completion of the questionnaires. Completion time of the
survey averaged 10 to 15 minutes. In addition to the questionnaires, each participant was
provided with an unmarked envelope in which to seal their completed questionnaires.
Completed surveys were returned to the nursing staff, who deposited them in a secured
drop-box which was provided on each unit.
Data Screening and Analysis
Data was analyzed using the Statistical Package for the Social Sciences (SPSS)
16.0. A two-tailed alpha of .05 was used to determine the significance of statistical
findings. Prior to data analysis, 20% of the data was randomly checked for accuracy of
data entry. No errors were found. All collected data were screened for issues with missing
data, outliers, multicollinearity, singularity and normality. Univariate statistical
procedures included student t-tests, chi-square analysis and Pearson correlation.
Multivariate analyses consisted of multivariate analysis of covariance (MANOVA) and
multivariate analysis of covariance (MANCOVA). A detailed discussion of the screening
and cleaning of data, and testing of assumptions for each of the aforementioned
procedures is described in Chapter IV.
Protection of Human Subjects
This study conformed to Tri-Council Standards for the ethical conduct of
research. As previously stated, approval for this study was sought from the Research
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Ethics Boards of the University of Windsor, Hotel Dieu-Grace Hospital, Windsor
Regional Hospital and Chatham-Kent Health Alliance. Participants were selected from
those wishing to participate based upon the inclusion and exclusion criteria. Participants
were provided copies of the letter of information and informed consent prior to
participating in the study (Appendix B). In addition, a copy of the information collected
from the participants' charts was attached to the consent. The consent form included
information regarding the investigator, purpose of the study, procedures, potential risks
and benefits, confidentiality and anonymity. A signed consent form was obtained from
each participant. Patients were assured that their decision to participate or not participate
did not affect their care in any way. Anonymity of participant response was protected
through the use of pre-assigned codes on the data collection sheets that did not disclose
the patients' identity. All hard data is, and will continue to be stored in a locked cabinet.
This data is accessible only to members of the research team. Electronic data was and is
saved in a password protected computer program. The data will be kept on file until
2012. The data may be used for subsequent research studies. Following this date, the hard
data will be destroyed by shredding and all electronic data will be permanently deleted.
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CHAPTER IV
RESULTS
This chapter summarizes the results of the statistical analyses. A description of
the data screening and cleaning process is provided, followed by a summary of sample
characteristics. Finally, the analysis associated with each of the three research questions
is presented.
Data Screening and Analysis
When the database was screened for missingness, there were missing data on the
following items from the psychometric measures of mood: unworthy, sluggish, furious,
uneasy, interference of sleep problems with daily functioning and noticeability ofsleep
problem to others. These items had one or two missing values each, yielding a total of 10
missing values. In order to avoid dropping these cases, which would result in a reduction
in sample size, thus compromising statistical power (Patrician, 2002), case mean
substitution was used to replace these missing values. This involves replacing a missing
value with the mean of the remaining items for that case (Raymond, 1986), and is
considered appropriate for the imputing ordinal missing values in a psychometric Likerttype scale (El-Masri & Fox-Wasylyshyn, 2005).
As the focus of this study is to determine the impact of smoking cessation on
patients with AMI, the variables non-smoker (never smoked) and past-smoker (quit
greater than one month ago) were collapsed together to form the true representation of the
variable non-smoker. That is, the literature suggests that the physiological and
psychological symptoms of withdrawal return to precessation levels 30 days after quitting
(Hughes, 1992). In addition, as each of the measures of mood was considered an
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individual indicator of stress, the scores from each item were summed to provide the total
score on each of the following measures of mood: anxiety, depression, anger, fatigue and
insomnia.
Testing ofAssumptions
The univariate statistics used in this study met the following assumptions: absence
of outliers, normality and linearity. Screening of univariate outliers was performed using
histograms, box plots and z-score statistics with a cut-off of 3.29. Variables were
screened for normal distribution using skewness and kurtosis statistics and histograms.
Given a small study sample, a critical value of + 2.58 was used to evaluate the
significance of skewness and kurtosis in this study (Stevens, 1996). In all variables with
outliers, return of such values to next highest value plus 1 resulted in a normal
distribution of the variable. Histograms and Q-Q plots were used to inspect all continuous
variables for linearity. As were no occurrences of re-infarction or ventricular fibrillation,
these variables were not included in the statistical analysis. With the exception of the
variable, ventricular tachycardia, linearity was achieved in all variables which were
included in the analysis. Unsuccessful transformation of the variable, ventricular
tachycardia, resulted in dichotomization of this variable. Tables 2 and 3 summarize the
testing, results and treatment of the dependent variables.
The assumptions of MANOVA and MANCOVA include the above, in addition to
the necessity to meet homogeneity of covariance matrices. That is, the variances in each
of the groups of interest (smokers and non-smokers) are roughly equal. Furthermore, in
the case of MANCOVA, the covariate must be a normally distributed continuous

1.46

9.62 + 7.58

Smoker

1.68
0.49

6.69 + 5.31

Smoker

2.96

2.86

6.59

2.96

3.04

0.45

2.20

Skewness

Non-smoker 10.18 + 7.06

5.29 + 5.48

4.17 + 3.75

Smoker

Non-smoker

1.68 + 2.49

Non-smoker

4.59 + 3.27

Smoker

replaced with next highest value +1

Insomnia

Fatigue

Anger

2.75 + 3.09

Non-smoker

5.76 + 3.45

Smoker

Depression

3.50 + 3.46

Non-smoker

Anxiety

M + SD

Smoking
Status

Variable

-0.78

-1.43

-0.50

0.78

2.65

12.33

3.38

1.02

-0.22

-0.08

Kurtosis

Raw Data

Normality Statistics for Psychological Indicators of Stress

Table 2
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0

0

0

3*

1*

1*

1*

2*

0

0

Outliers

Skewness

1.30

1.33

1.82

-1.61

2.12

No Treatment Required

No Treatment Required

No Treatment Required

4.32 + 3.57

4.00 + 3.27

1.32 + 1.39

4.07 + 2.15

2.64 + 2.79

No Treatment Required

-1.03

0.35

-0.78

-0.73

-0.15

Kurtosis

No Treatment Required

M + SD

Treated Data

1.12 + 2.73
.52 + 1.53

Smoker

* replaced with next highest value +1

Ventricular
Tachycardia

Non-smoker

2.38 + 3.07

Smoker

9.90

5.90

2.23

3.59

4.09

4.07 + 5.55

Non-smoker

Ischemia

-0.88

1.08

4.38+1.68

Smoker

26.35

7.42

-0.37

4.00

3.11

4.32+1.68

Kurtosis

Non-smoker

Skewness

Length of
Stay

M + SD

Smoking
Status

Variable

Raw Data

Normality Statistics for Physiological Indicators of Stress

Table 3
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4

5

0

4*

0

1*

Outliers

2.25

Skewness

2.32

-0.36

Variable Dichotomized

Variable Dichotomized

No Treatment Required

3.43 + 3.95

1.22

Kurtosis

No Treatment Required

4.36 + 1.68

M+SD

Treated Data
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variable. Homogeneity of variance was tested for all variables through determination of
the Levene's statistic. The Levene's test was violated in all of the variables with the
exception of the variable anger. This was not considered an issue, as interpretation of the
results for the statistical tests employed take into account the violation of this test.
Sample Characteristics
Subjects were recruited from three hospitals, two in Windsor, Ontario (n = 42)
and one in Chatham, Ontario (n = 18). Of the 60 patients enrolled, 57 cases were valid for
inclusion in the analysis. The three cases that were deleted from the study had missing
data which represented greater than 20% of the survey. The mean age of the sample was
58 years (SD + 10.47). The majority of patients in the sample were diagnosed with their
first AMI (n = 39; 86%). Fifty-one percent (n = 29) were actively smoking prior to
admission to the hospital, and 79.3 % (n = 23) of these same participants reported
experiencing symptoms of withdrawal. The majority of participants reported their
ethnicity as white (n = 51; 89.5%), with men comprising 71.9% (n = 41) of the sample.
The mean CCU length of stay was 4.35 days (SD ± 1.63), while the mean number of
ischemic episodes was 2.89 (SD + 3.56). A summary of the sample characteristics is
presented in Table 4.
Research Question 1
The first research question examined the difference in the psychological
indicators of stress between smoking and non-smoking AMI patients. The dependent
variables include measures of tension/anxiety, depression/dejection, anger/hostility,
fatigue/inertia and insomnia. Following data cleaning, all of the aforementioned variables
were found to be normally distributed. The univariate analysis suggested that there were
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Table 4
Sample Characteristics
Variable

Smoking Status

Smoking

Non-smoking

N{% total)

N(% total)

29(51.0%)

28 (49.0%)

57(100%)

21 (36.9%)

20 (35.0%)

41 (71.9%)

8 (14.0%)

8 (14.0%)

16 (28.0%)

N(% total)

Gender
Male
Female

Marital Status
Married

14 (24.6%)

16 (28.0%)

30 (52.6%)

Single

5 (8.8%)

4 (7.0%)

9(15.8%)

Widowed

2 (3.5%)

4 (7.0%)

6(10.5%)

Divorced/separated

6 (10.5%)

3 (5.3%)

9(15.8%)

Common law

2 (3.5%)

1 (1.8%)

3 (5.3%)

White

26 (45.6%)

25 (43.9%)

51 (89.5%)

Black

1 (3.4%)

0

(0.0%)

1 (1.8%)

Asian

1 (3.4%)

0

(0.0%)

1 (1.8%)

Aboriginal

3 (5.3%)

0

(0.0%)

3 (5.3%)

Other

0 (0.0%)

1

(3.4%)

1 (1.8%)

Ethnicity
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Smoking

Non-smoking

n (% total)

n (% total)

Full-time

16(28.1%)

6 (10.5%)

22 (38.6%)

Part-time

2 (3.5%)

8 (14.0%)

10 (17.5%)

Casual

2 (3.5%)

1 (1.8%)

3 (5.3%)

Unemployed/retired

9(15.8%)

13 (22.8%)

22 (38.6%)

19 (33.3%)

11(19.2%)

30 (52.5%)

College

8 (14.0%)

12(21.1%)

20(35.1%)

University

2 (3.5%)

3 (5.3%)

5 (8.8%)

Graduate degree

2 (3.5%)

0 (0.0%)

2 (3.5%)

Yes

4 (7.0%)

6 (10.5%)

10 (17.5%)

No

21 (36.9%)

18(31.5%)

39 (68.4%)

4 (7.0%)

4 (7.0%)

8 (14.0%)

Variable

N(% total)

Employment

Education
High school or less

Previous AMI

Don't know
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significant differences between smokers and non-smokers on the anxiety (t = -2.468; p =
.017), depression (t = -2.\64;p = .035), and anger (t = -4.046;/? = .000). That is, smokers
reported significantly higher levels of anxiety, depression, and anger than non-smokers
while hospitalized in the CCU following AMI (Table 5).
MANOVA was performed to examine the adjusted difference between smokers
and non-smokers on each of the dependent variables. That is, while holding all else
constant, MANOVA allows the examination of the mean differences between smokers
and non-smokers while taking into account the any correlations that might exist between
the outcome variables. In addition to the univariate assumptions, the following
assumptions were tested and met prior to analysis: multivariate normal distribution of the
dependent variables and multivariate homogeneity of covariance matrices (p value for
Box's M = .350). The Levene's test of homogeneity of variance indicated that the two
groups had equal variance in all dependent variables (p > .05), except for anger (p < .05).
However, MANOVA is known for its robustness to violation of homoegeneity of
variance when the analysis is conducted on equal groups (Tabachnick & Fidell, 1996).
Given that MANOVA assumes that the outcome variables be correlated, Pearson
correlation was performed in order to determine the correlations between each of the
dependent variables. The data suggested that correlations existed among the following
variables: fatigue, depression, anger, insomnia and anxiety. A correlation matrix
describing the statistical relationship among the variables is provided in Table 6.
Therefore, all of the correlated psychological measures of stress were entered into one
MANOVA model.
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Table 5
Summary oft-test Comparisons for the Psychological Indicators of Stress
Variable

M+SD

t

Non-smoker

3.50 + 3.46

-2.468

.017

Smoker

5.76 + 3.45

Total

3.68 + 3.28

-2.164

.035

-1.970

.054

-4.046

<.001

Depression
Non-smoker

2.64 + 2.79

Smoker

4.59 + 3.27

Total

4.65 + 3.61

Fatigue
Non-smoker

5.29 + 5.48

Smoker

6.69 + 5.31

Total

6.00 + 5.39

Anger
Non-smoker

1.32+1.39

Smoker

4.17 + 3.75

Total

2.95 + 3.41

Insomnia
Non-smoker

10.18 + 7.06

Smoker

9.62 + 7.58

Total

9.89 + 7.36

.284

.778
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Table 6
Correlation Matrix of the Relationship Among the Psychological Indicators of Stress
Variable

1

2

3

2. Depression

.623*

1

3. Anger

.358*

.644*

1

4. Insomnia

.463*

.193

.209

5. Anxiety

.685*

.781*

.618*

3

5~~

.341*

1

* correlation is significant at < .05

The findings suggested that after controlling for the correlations among the
dependent variables, the levels of depression (F = 4.07; p = .034), anxiety (F = 6.09; p
.017), and anger (F = 8.67; p = .005) of AMI patients were impacted by smoking status.
That is, smokers had significantly higher levels of depression (M = 4.59 + 3.27), anxiety
(M = 5.76 + 3.45) and anger (M = 4.17 + 3.75) as compared to the non-smokers (means =
2.64 + 2.79; 3.50 + 3.46; and 1.32 + 1.39, respectively). However, there was no overall
multivariate difference between smokers and non-smokers (F = 28.176;/? = .073). In
addition, the univariate comparisons on depression, anxiety, and anger were identical to
those obtained from the unadjusted Hest analysis. These results are summarized in
Tables 7 and 8.
Multiple analysis of covariance (MANCOVA) was then conducted to determine if
there were any covariates influencing the impact of smoking status on each of the
dependent variables. Given that only continuous variables can be included as covariates
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Table 7
MANOVA Analysis on the Impact of Smoking on the Psychological Indicators of Stress
Variable

M+SD

F

p

Non-smoker

3.50 + 3.46

4.75

.034

Smoker

5.76 + 3.45

6.09

.017

8.67

.005

.96

.330

.081

.778

Depression
Non-smoker

2.64 + 2.79

Smoker

4.59 + 3.27

Anger
Non-smoker

1.32 ±1.39

Smoker

4.17 + 3.75

Fatigue
Non-smoker

5.29 + 5.48

Smoker

6.69 + 5.31

Insomnia
Non-smoker

10.18 + 7.06

Smoker

9.62 + 7.76

in MANCOVA, univariate analysis was conducted on the continuous variables that
conceptually may have had a confounding effect on the psychological indicators of stress.
The results of the analysis demonstrated that age was the only potential confounder. As a
result, MANCOVA was performed to determine the effect of smoking cessation on each
of the measures of mood while adjusting for age. The findings suggested that after
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adjusting for age, there was an overall multivariate difference between smokers and nonsmokers (F = 3.128;/? = .016). Furthermore, the levels of depression (F = 4.814;/? =
.033), anxiety ( F - 7.991;/? .007), and anger (F = 6.125;/? - .017) of AMI patients were
impacted by smoking status. That is, smokers had significantly higher levels of
depression (M = 4.59 + 3.27), anxiety (M = 5.76 + 3.45) and anger (M = 4.17 + 3.75) as
compared to the non-smokers (means = 2.64 + 2.79; 3.50 + 3.46; and 1.32 + 1.39,
respectively). These results are summarized in Tables 8 and 9.
Table 8
Multivariate MANCOVA Results for Smoking and Age
Variables
Dependent
Variables

Wilk's>,

F

p

Effects

Anxiety
Depression

Smoking

.762

3.128

.016

Age(cov.)

.793

2.613

.036

Anger
Fatigue
Insomnia
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Table 9
Post-hoc Univariate MANCOVA Comparisons After Adjustingfor Age
Effect

M+SD

F

Anxiety
Non-smoker

3.50 + 3.46

Smoker

5.76 + 3.45

7.991

.007

4.814

.033

6.125

.017

.403

.528

1.099

.299

Depression
Non-smoker

2.64 + 2.79

Smoker

4.59 + 3.27

Anger
Non-smoker

1.32+1.39

Smoker

4.17 + 3.75

Fatigue
Non-smoker

5.29 + 5.48

Smoker

6.69 + 5.31

Insomnia
Non-smoker

10.18 + 7.06

Smoker

9.62 + 7.58

Research Question 2
The second research question was aimed at determining the differences in the
functional outcomes of smoking and non-smoking AMI patients following AMI, as
measured by length of stay, arrhythmia, re-infarction and cardiac ischemia. As there were
no occurrences of re-infarction in the study, statistical analysis was not conducted on this
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variable. Furthermore, after exploring the variable arrythmia, there were no episodes of
ventricular fibrillation in either the smoking or the non-smoking group. Therefore
analysis was conducted on the variable ventricular tachycardia only.
Student Mest comparisons were conducted on the continuous outcome variables
(length of stay and cardiac ischemia). Prior to analysis, all assumptions of the statistical
test were verified as being met. The data suggested that there were no significant
differences between smoking and non-smoking AMI patients with respect to length of
stay in the CCU (4.34 and 4.36 days; t = .028; p = .978) and episodes of cardiac ischemia
(2.38 and 3.43 episodes; t=l.ll;p

= .272).

Given that the variable, ventricular tachycardia was dichotomized, chi square
analysis was conducted to determine if there was a difference in the occurrence of
ventricular tachycardia among AMI patients who reported smoking prior to admission
and those who reported non-smoking. The data suggested that there was no difference in
episodes of ventricular tachycardia among smokers and non-smokers (%2 = .073; p =
.786).
MANO VA was not performed on the physiological indicators of stress because
Pearson correlation demonstrated that the variables length of stay and cardiac ischemia
were not correlated (r = . 142; p = .293).
Research Question 3
The third research question examined the relationships between the physiological
indicators of stress and the psychological well-being of smokers and non-smokers
following AMI. Given that all variables, except for the variable ventricular tachycardia,
were measured as continuous variables, two statistical tests were conducted. First,

55
Pearson moment correlation was performed to explore the correlations among the
continuous variables: length of stay, cardiac ischemia, depression, anxiety, anger, fatigue
and insomnia. Next, the differences in the psychological indicators of stress between
those who experienced ventricular tachycardia versus those who did not were explored
through the use of student Mests. Pearson moment correlation revealed that there was
only one statistically significant relationship among the psychological and physiological
indicators of stress. That is, the variables, insomnia and ischemia were significantly
correlated (r = .289; p = .029). The correlation matrix in Table 10 displays all correlation
coefficients of the explored associations. .
Finally, the results of the r-tests suggested that there was no significant difference
between those who experienced ventricular tachycardia versus those who did not on any
of the psychological measures of mood. That is, depression (t = .155;/? = .878), anxiety (t
= 382; p = .704), anger (f = -.154;/? = .878), fatigue (f = -.681;/? = .498), and insomnia (t
= -.007; p = .994) were not significantly different between the two groups of patients
(Table 11).
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Table 10
Correlation Matrix Explaining Relationships among the Continuous Outcome Variables

Variable

1

1. Fatigue

1

3

2

4

5

6

2. Depression

.623*

1

3. Anger

.358*

.644*

1

4. Insomnia

.463

.193

.209

5. Anxiety

.685*

.781*

.618*

.341*

1

6. Length of Stay

.254

.101

-.054

.125

.137

1

7. Ischemia

.246

.031

-.025

.289*

.062

.142

7

1

1

* correlation is significant at <.05
Table 11
T-test Comparisons: Ventricular Tachycardia (Vtach) and Psychological Measures
Variable

M+SD

t

p

.382

.704

.155

.878

Anxiety
Experienced vtach

4.74 + 3.62

Did not experience vtach

4.27 + 3.72

Depression
Experienced vtach

3.72 + 3.28

Did not experience vtach

3.54 + 3.47
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Variable

M+SD

t

p

Anger
Experienced vtach

2.91 + 3.36

Did not experience vtach

3.09 + 3.75

-.154

.878

-.681

.498

-.007

.994

Fatigue
Experienced vtach

5.76 + 5.42

Did not experience vtach

7.00 + 5.42

Insomnia
Experienced vtach

9.89 + 7.57

Did not experience vtach

9.91 + 6.73
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CHAPTER V
DISCUSSION
This chapter presents a discussion of the study results. Each research question will
be examined individually, with a focus on: (a) degree of fit with the theoretical
framework, and (b) congruence and/or lack of congruence with the existing literature.
Implications for nursing research and nursing practice will be provided, followed by
limitations of the study. This section will conclude with a summary of the discussion.
Research Question 1
The first research question examined the difference in the psychological
indicators of stress between smoking and non-smoking AMI patients. The model adapted
for the study (Lazarus & Folkman, 1984) posited that smokers who were unable to use
smoking as a coping effort would experience higher levels of stress (as measured by
depression, anxiety, anger, fatigue, and insomnia) than non-smokers. Overall, the
findings supported this supposition. That is, smokers reported higher levels of depression,
anxiety, and anger than non-smokers. This is not surprising given that several researchers
reported these mood states to be typical symptoms of nicotine withdrawal (Gritz et al.,
1991; Tsuda et al., 1996; VanderKaay & Patterson, 2006). However, there were no
differences between smokers and non-smokers with respect to fatigue and insomnia. The
outcomes associated with each of the measures of mood are discussed individually in the
following text.
The Impact of Smoking Cessation on Anxiety
The findings of this study support those of other previous researchers who
reported higher levels of anxiety among individuals who experience abrupt nicotine
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withdrawal (Gritz et al., 1991; Hughes, 1992; VanderKaay & Patterson, 2006). In fact,
although anxiety was highly correlated with both depression and anger, these patients had
higher levels of anxiety even after adjusting for depression and anger. This finding
supports the notion that smokers will likely experience increased levels of anxiety when
hospitalized for AMI. This may be due to a combination of the physiological effects of
nicotine withdrawal and a variety of psychological factors. Current standard of care is to
administer anti-anxiety medications to patients who are having difficulty coping with the
symptoms of nicotine withdrawal and/or the experience of AMI. Although the use of
MANCOVA in this study did not allow for the control of categorical data (covariates can
only be continuous variables), it is important to note that more smokers (66%; n = 19)
received anti-anxiety medications, as compared to non-smokers (46.4%; n - 13), lending
further support to the study findings.
As previously stated, it is possible that the anxiety experienced by smokers
following AMI is also due to psychological factors. For example, the symptoms of
anxiety may be exacerbated by fear of ability to successfully quit smoking. In this study,
almost 90% (« = 26) of smokers indicated definite plans to quit smoking in the next
month, yet 93% (n = 27) had been unsuccessful in past attempts. In fact, 54% (n = 15)
reported having had three or more unsuccessful quit attempts in the past. Given that
patients have reported smoking as a causal factor in AMI (Clark, 2003; Condon &
McCarthy, 2006; Fukuoka et al., 2004; King, 2002; McKibbin & Wilson, 2001), it is
therefore likely that past failed attempts may contribute to increased anxiety among
smokers who experience AMI. That is, when a smoker identifies smoking as a cause of
his/her AMI and reflects upon past unsuccessful quit attempts, these processes may

60
combine to produce greater stress among this group of smokers than smokers who have
not previously attempted to quit smoking. Furthermore, with the exception of enforced
smoking cessation, it may be assumed that the stressors associated with AMI are similar
for both smokers and non-smokers. These stressors may include fear of death, lifestyle
modifications and impact on job and/or family. In the case of a non-smoker, he or she
may still be able to utilize his or her usual coping strategies in the CCU environment.
However, smokers are unable to rely upon smoking as means of coping, and this may
heighten the anxiety associated with the experience of AMI.
The Impact ofSmoking Cessation on Depression
The findings of this study suggest that smokers had higher depression scores than
non-smokers. These findings are congruent with research literature that suggests
depression is a symptom of smoking withdrawal (Hughes, 1992; VanderKaay &
Patterson, 2006). In fact, Hughes found a correlation between cigarette craving and
depression. More importantly, the results of this study revealed that smokers experienced
higher levels of depression, regardless of their levels of anxiety and/or anger.
Interestingly, Kuhn (1996) reported a converse relationship between smoking cessation
and depression, wherein smokers experienced lower depressive symptomatology than
non-smokers following AMI. Kuhn hypothesized that non-smokers were searching for a
reason for their AMI, whereas smokers had an identified cause and were therefore less
depressed. This hypothesis is yet to be validated in any existing literature. Furthermore, it
must be noted that Kuhn's study was limited by two methodological concerns: (a) smaller
sample size (n - 40); and (b) data collection procedures that occurred over an extended
period from hospitalization to post-discharge, in which case, control over smoking status
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was not maintained. In addition, time of data collection was not consistent with peak
withdrawal, which occurs in the first two days following smoking cessation (Gritz et al.,
1991; Hughes, 1992).
As previously suggested, depression among smokers is likely related to the
physiological result of nicotine withdrawal and a combination of other psychological
factors. Specifically, it is possible that an individual who smokes may experience higher
levels of depression due to apprehension and/or worry concerning his/her ability to
successfully quit. Although the full impact of these psychological factors on the
depression scores of smokers is not known, the methodology and statistical techniques
employed in this study likely provide sufficient evidence to support thefindings.That is,
smokers experienced higher levels of depression and this is most probably due to abrupt
smoking cessation. Further research in this area is warranted to fully examine the
relationship between smoking cessation and depression in this population.
The Impact ofSmoking Cessation on Anger
In this study, smokers reported significantly higher levels of anger than nonsmokers. This finding is congruent with those of several researchers who reported an
association between anger and smoking status (Hughes 1992; Tsuda et al., 2006;
VanderKaay & Patterson, 2006). In particular, these researchers attributed anger to abrupt
withdrawal from nicotine. Although smokers in this thesis study were subjected to abrupt
smoking cessation, there were likely other factors that also contributed to their increased
levels of anger. For example, given that patients have attributed smoking as a causal
factor in AMI (Clark, 2003; Condon & McCarthy, 2006; Fukuoka et al., 2004; King,
2002; McKibbin & Wilson, 2001), it is possible that smokers experience resentment
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towards their current smoking behaviours. In addition, it may be hypothesized that these
feelings of anger are heightened by prior unsuccessful quit attempts.
The Impact of Smoking Cessation on Fatigue
The data suggested no association between fatigue and abrupt nicotine
withdrawal, a relationship that has not been investigated in previous research. This
finding may be explained by the fact that almost half (n = 27) of the study participants
received sedation while hospitalized in the CCU. In fact, the results showed that an
interesting 55% (n = 16) of smokers were sedated as compared to 39% (n = 11) of nonsmokers. Given that more smokers received sedation as compared to non-smokers, it may
follow that if sedation could be held constant, smokers may actually experience more
fatigue than non-smokers. Unfortunately, MANCOVA assumptions did not allow for
inclusion of this categorical variable as a covariate.
The Impact of Smoking Cessation on Insomnia
Contrary to VanderKaay and Patterson (2006) who reported insomnia as a
symptom of nicotine withdrawal, the findings of this study suggested no difference
between smokers and non-smokers with regard to their insomnia. Although the
theoretical model (Lazarus & Folkman, 1984) proposed that smokers and non-smokers
would differ with regard to insomnia, it is likely that this relationship was masked by the
administration of sedation. As previously presented, sedation was administered to almost
half of the patients in this study (47%; n = 27), 60% of whom were smokers.
Research Question 2
The data did not support a difference in the functional outcomes of smokers and
non-smokers when hospitalized with AMI. These results do not fit the propositions of
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Lazarus and Folkman's (1984) Transactional Model of Stress and Coping. This model
suggests that smokers who are unable to use smoking as a coping strategy will experience
different functional outcomes as compared to non-smokers. In this study, smokers and
non-smokers did not differ with regard to CCU length of stay, episodes of cardiac
ischemia, arrhythmia or re-infarction. In fact, no participants experienced either reinfarction or ventricular fibrillation. These findings contradict that of Mayou et al. (2000)
who reported a relationship between distress and longer hospital stay. There are a variety
of reasons to explain this inconsistency in the findings. First, it is important to note that
Mayou and colleagues published no supporting data for this result, and therefore
Mayou's findings must be questioned. Second, this study examined length of stay in the
CCU only, while Mayou et al. studied the impact of stress on total hospital stay. It is
possible that symptoms of distress increase after transfer from the CCU because patients
no longer receive the same level of individualized care as provided in the CCU. Thus, the
impact of smoking cessation on length of stay may be better measured by total length of
hospital stay. Third, length of stay in CCU is likely attributed to additional factors which
were not considered in the study. Specifically, bed availability on a telemetry unit often
determines when AMI patients are transferred from the CCU. Furthermore, AMI patients
often undergo cardiac catheterization, which may delay transfer to a step-down unit.
There are no known studies which have examined the direct impact of smoking
cessation on the physiological impact of AMI patients. However, Moser and Dracup
(1996) reported that anxiety predicted cardiac complications, such as cardiac ischemia,
ventricular fibrillation and re-infarction, among hospitalized AMI patients. These
findings were not supported by this study. Nevertheless, it must be noted that Moser and
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Dracup's findings represent an indirect relationship between smoking status and
functional outcomes. Furthermore, Moser and Dracup's study was conducted on a
relatively larger sample (N= 86), which may have provided the statistical power required
to detect differences between the groups. In addition, it is possible that anxiety levels
among participants in this study were not high enough to impact the physical outcomes.
This may be explained by the fact that the 56% (n = 32) patients in this study received
anxiolytics. Data were collected with respect to such medications, however, given that
they were categorical variables, they could not be included as a covariate in the analysis.
Furthermore, ischemia was measured through administration of either morphine or
nitroglycerin on an as needed basis. It is important to note that it is standard practice in a
CCU to administer nitroglycerin intravenously to control ischemia in a patient who
continues to experience frequent symptoms of angina. Hence, all episodes of cardiac
ischemia may not have been accounted for.
Research Question 3
The Transactional Model of Stress and Coping (Lazarus & Folkman, 1984)
proposed a relationship between the psychological and physiological indicators of stress.
In this study, AMI patients who experienced cardiac ischemia also experienced insomnia.
This is likely explained by two presumptions: (a) either these patients were awakened by
the discomfort associated with angina; or (b) these patients were troubled by the
possibility of experiencing angina, and therefore, experienced sleep disturbances.
Although the model proposed a relationship among the remaining variables, there were
no other significant relationships between the psychological and functional outcomes.
These findings were incongruent with the findings of Moser and Dracup (1996) who
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reported a significant relationship between high anxiety levels, ischemia, re-infarction
and ventricularfibrillation.However, it is important to note that Moser and Dracup's
study was published in 1996 and that the treatment of patients experiencing AMI has
progressed since that time. In this study, no participants experienced any episodes of reinfarction or ventricular fibrillation.
Implications
Implications for Nursing Practice
This is a pilot study that was conducted on a relatively small sample. Thus, it is
difficult to infer that thefindingsof this study provide prescription for practice. However,
thefindingsof this study suggest the need for nurses to fully assess and intervene to meet
the emotional needs of their AMI patients. Given that psychological distress among AMI
patients is associated with mortality (Ariyo et al., 2000; Frasure-Smith et al., 1993; Grace
et al., 2005), in-hospital complications (Moser & Dracup, 1996), and subsequent distress
(Bennett et al., 1999; Brown & Mumford, 1984; Chalfont and Bennett, 1999; Lowe et al.,
2000; Mayou et al, 2000), the importance of reducing psychological stress among AMI
patients is essential. More importantly, this study highlights the need for ongoing
assessment and treatment of anxiety, depression, and anger among AMI patients who are
experiencing nicotine withdrawal symptoms. Although it is common for such patients to
receive anti-anxiolytics medications to reduce anxiety, only 65.5% (n = 19) received such
medications. This is concerning given that 79.3% (n = 23) of smokers reported
experiencing one or more symptoms of nicotine withdrawal. Currently, it is not common
for AMI patients to receive nicotine replacement or pharmacological smoking cessation
aids in the initial phase following AMI. Thus, it may be useful to recommend that
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consideration be made with regard to the efficacy and safety of such aids in this patient
population. This is especially important given that high stress may hamper smoking
cessation (Brown & Mumford; Rose etal., 1994). Therefore, not intervening may create a
cyclical pattern of stress, leading to further stress and the inability to successfully quit, all
of which may increase the mortality associated with cardiovascular disease.
Although no physiological complications associated with nicotine withdrawal
were found in this study, previous research (Moser & Dracup, 1996) suggests that this
relationship exists. This may be attributed to the small sample of this study. Thus, it is
important that this association be further investigated, and that diligent assessment of
complications among smokers who experience AMI continues.
Implications for Nursing Research
The findings of this study highlight the need for further research related to the
impact of abrupt smoking cessation among hospitalized AMI patients. First, replication
of this study with a larger sample is important to validate the findings. To better
understand the relationship between smoking and length of stay, replication of this study
examining the total length of hospitalization from admission to discharge is
recommended. Given that only 29% of participants in the study were women, it is
difficult to infer any conclusions related to gender differences and smoking cessation
following AMI. Therefore, further research is recommended to more fully understand any
relationships that might exist.
Although the impact of abrupt nicotine withdrawal on the mood of individuals
who smoke is well reported in the literature, less is known about smokers who are
hospitalized for AMI. Furthermore, the psychological factors which may enhance the
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distress of hospitalized AMI patients who smoke are even less understood. Thus, it is
important that further studies examining this relationship be conducted to develop a
complete understanding of the impact of smoking cessation on mood. Attention should be
given to smoking history, specifically the desire to quit smoking and the number of
previous quit attempts. Finally, the results of this study lend support for intervention
research to determine the efficacy and appropriateness of smoking cessation aids for
smokers who are hospitalized with AMI. Such a study could also examine the
longitudinal impact of early intervention on quit success, as well as the mortality of
cardiac patients who smoked prior to experiencing AMI.
Implications for Nursing Education
This study offers implications for both the education of nurses and patients. It is
prudent that critical care curricula and institutional orientation programs for nurses
working with cardiac populations include content related to smoking cessation and AMI.
That is, nurses need to recognize the possible impact of abrupt nicotine withdrawal on the
psychological and physiological stress of AMI patients. Furthermore, health care
professionals require education related to the management of symptoms of nicotine
withdrawal in this population.
Regarding patient education, nurses should instruct smokers who are experiencing
AMI that symptoms of anxiety, depression, and anger are possible after experiencing a
heart attack and that it is essential that patients recognize these symptoms and report them
to the health care team. From a health promotion perspective, education concerning the
risks associated with nicotine use is paramount. Specifically, this education should
include the risk factors associated with mood changes and possible complications that
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may occur following AMI. This represents additional information that may inhibit
initiation of smoking, or promote smoking cessation among patients prior to experiencing
an AMI.
Limitations
Although this study adds to the empirical evidence regarding the impact of
smoking cessation on patients who experience AMI, it is not without limitations. These
limitations can be summarized by issues related to the following: (a) sample size; (b)
statistical restrictions; (c) the observational nature of the study, and (d) recruitment
issues. Although the study was pilot in nature, 57 participants is likely not sufficient to
provide significant power to detect the full impact of smoking cessation on this
population. However, despite the relatively small sample, the findings suggested that
smoking cessation has a negative impact of the psychological indicators of stress among
AMI patients.
The choice of statistical application limited the testing of possible confounding
variables in the relationships. That is, there were several variables for which data was
collected that may have possibly confounded the relationships among the variables.
Unfortunately, MANCOVA requires that covariates are continuous variables. Therefore,
the statistical procedures were unable to control for the possible impact of such variables
as, medications, smoking history, cardiac catheterization and previous AMI on the
outcome variables. Given the observational nature of the study, no causality could be
inferred. In addition, the self report nature of responses introduces a potential for
response bias. Finally, the demographic characteristics of the study population may limit
the generalizability of the results. Although the intent was to recruit participants from a
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variety of racial and socio-economic groups, this study included participants who were
primarily Caucasian. This may be attributed to the fact that the inclusion criteria required
that participants possess the ability to read and understand English. Therefore, it is
possible that this criterion limited the number of subjects from non-traditional ethnic
groups who were otherwise eligible to participate: Furthermore, given that the majority of
participants were male, the impact of abrupt smoking cessation on females is not fully
understood.
Conclusions
The purpose of this study was to develop a better understanding of the impact of
abrupt smoking cessation on patients who experience AMI. The findings suggest
congruence with some of the relationships between the concepts in the adapted
theoretical framework. Overall, smoking status did significantly impact the psychological
stress of AMI patients, but did not appear to impact the functional outcomes of this
population. In addition, there was only one significant relationship between the
psychological and physiological indicators of stress. The discussion addressed the issues
related to the significant findings and provided plausible explanations for the nonsignificant results. This study offers noteworthy implications for theory development,
nursing practice, education and research. In light of the limitations of this study, it is
recommended that further investigation be conducted.
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APPENDIX A
Data Collection Forms

Dear Participant,
This survey is designed to better understand your stress levels after the
experience of your heart attack and whether smoking cessation due to
hospital admission has an impact on these stress levels. The survey consists
of three parts: the Profile of Mood States, and the Insomnia Severity of
Index, and a questionnaire that asks information about your health and
smoking status. Please follow the instructions that are included at the
beginning of each questionnaire and complete them as best fits your
experience since being hospitalized. Please note that in this study, smoking
refers to the use of any nicotine product, such as cigarettes, cigars, pipes
and/or chewing tobacco.
When you have completed all three parts of the survey, please seal all three
of your answer sheets in the provided envelope. Once you do that, you may
ask one of the nurses in the unit to place the envelope in the secured box that
I will make available on the unit. Envelopes deposited in the box will be
collected by a member of the research team at a later time.
Thank you for taking the time to participate in this study.

KathyPfaff,RN,BScN
Master's Student Investigator
University of Windsor
Faculty of Nursing
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Profile of Mood States Brief

Instructions:
Below is a list of words that describe feelings that people have. Please read each word
carefully. Then circle the number that best describes how you feel right now.

Item#

Item

1.

Tense

2.

Not at all

A little

Moderately

Quite ai bit

Extremely

0

2

3

4

Angry

0

2

3

4

3.

Worn out

0

2

3

4

4.

Sad

0

2

3

4

5.

Annoyed

0

2

3

4

6.

Anxious

0

2

3

4

© McNair, Lorr., & Droppelman, 1992
This represents six items of the 30 item POMS Brief. Written permission to use the
POMS Brief and to publish these items was granted by the publisher (Multi-Health
Systems Inc.).
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Insomnia Severity Index (ISO
For each question below, please circle the number corresponding most accurately to
your sleep patterns since being in the hospital.
For the first three questions, please rate the SEVERITY of your sleep difficulties.
1. Difficulty falling asleep:
None
Mild
0
1

Moderate
2

Severe
3

Very Severe
4

2. Difficulty staying asleep:
None
Mild
0
1

Moderate
2

Severe
3

Very Severe
4

3. Problem waking up too early in the morning:
None
Mjld
Moderate
0
1
2

Severe
3

Very Severe
4

4. How SATISFIED/dissatisfied are you with your current sleep pattern?
Very
Satisfied
0

Satisfied
1

Neutral
2

Very
Dissatisfied
4

Dissatisfied
3

5. To what extent do you consider your sleep problem to INTERFERE with
your daily functioning (e.g., daytime fatigue, ability to function at work/daily
chores, concentration, memory, mood).
Not at all
Interfering
0

A Little
Interfering

Somewhat
Interfering

1

2

Much Very Much
Interfering
Interfering
3

4

6. How NOTICEABLE to others do you think your sleeping problem is in terms of
impairing the quality of your life?
Not at all
A little
Noticeable Noticeable
0

Somewhat
Noticeable

1

Much
Noticeable

2

Very Much
Noticeable

3

4

7. How WORRIED/distressed are you about your current sleep problem?
Not at all

0

A Little Somewhat

1

Much

2

©Morin, C M . (1993, 1996, 2000, 2006).

Used and published with written permission of the author.

Very Much

3

4
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Demographic and General Information
1. Please indicate your age

2. Gender

3. Ethnicity
D white
D black
Dmale • female D asian
D aboriginal
• Hispanic D other

years
4. Marital Status

5. Employment Status

6. Dependent
Children at home

D married D single D widowed • full-time • part-time
• divorced/separated • common- • casual
law
• unemployed
7. Education
• high school or less D community college/diploma
• graduate degree

Dyes

Dno

D university degree

8. Current Medical Conditions
D high blood pressure
D lung disease
• heart failure

D diabetes
D cancer

• stroke
D anxiety disorder

• angina (chest pain)
D depression

9. Have you had more than one heart attack?
D yes D no D I don't know
*If your answer is no, or you don't know, please skip to question #12
10. Including this heart attack, how many heart attacks have you had?
D two D three D more than three
11. Besides this heart attack, when was your last heart attack?
D less than one month ago

D between one year and 5 years ago

D 1-6 months ago

• 6 months to one year ago

D greater than 5 years ago
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12. Have you ever had angioplasty?
• Yes

D No

DI don't know

13. Have you ever had heart bypass surgery?
D Yes

D No

14. Do you have a family history of heart disease?
D Yes

D No

D I don't know

15. Have you ever been admitted to hospital before?
D Yes

D No

If yes, how long ago were you in the hospital?
• less than one month

• 1-6 months

D between one year and 5 years

D 6 months to one year
• greater than 5 years

How long were you hospitalized?
D one day • 2 to 3 days • 4 to 7 days • greater than 7 days
16. Please indicate your current smoking status before this hospitalization.
D smoker

D non-smoker

D past smoker

* If you are a past smoker, please skip to question #23
*If you have never smoked, please skip to question #25
17. What do you smoke?
D cigarettes

• cigars

D pipe

• chewing tobacco
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18. On average, how many nicotine products (i.e. cigarettes, chewing tobacco) do
you use in a day?
Done D2to3 D4to6

• 7 to 10 • 11 to 20 • greater than 20

19. When did you last use a nicotine product?
• 2 days ago

D 3 to 6 days ago

D 1 to 2 weeks ago

D greater than 2 weeks but less than one month ago

D one month or more ago

20. Have you ever tried to quit smoking?
D Yes D No
If yes, how many times have you tried?
Dl
D2
D3
• 4 or more
If yes, what strategies did you use to help you quit?
• none
• nicotine patch
D nicotine gum
• medications

D counseling

• support group

21. If still smoking, do you plan to quit smoking?
D No, I am not thinking about quitting
D I am seriously thinking about quitting in the next 6 months
• I have made definite plans to quit in the next month
22. If you have already quit smoking, how long ago did you quit?
D less than 1 week D 1 to 4 weeks • 1 month to 6 months
U 6 months to 1 year D more than 1 year
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What strategies did you use to quit?
D none

D nicotine gum

D nicotine patches

D medication

D counseling

23. Are you experiencing any of the following withdrawal symptoms since your
hospitalization?
• irritability

D dry mouth

D difficulty sleeping

D tightness in chest

• fatigue

• difficulty concentrating

• sore throat • cough

24. Does your spouse or significant other smoke?
DYes

DNo

Thank you for your participation.

D none

D headache
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Chart Data Form
1. CCU Length of Stay
Admission date to CCU
Discharge datefromCCU
2. Peak Troponin level

3. Vital Signs
Blood pressure 1) on admission

2) at data collection

Heart rate 1) on admission

2) at data collection

4. Cardiac Ischemia
Number of events for which nitroglycerin or morphine was adrninistered
5. Reinfarcrion
• yes

D no

6. Arrhythmia
No. of episodes of ventricular tachycardia
No. of episodes of ventricular fibrillation
7. Medications
D sedative
D anti-anxiolytic
D anti-depressant
D beta blocker
D ACE inhibitor
D Nicotine replacement
8. Cardiac catheterization
D yes

D no

9. CCU Accommodation
D private room

• semi-private room
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APPENDIX B
Consent/Letter of Information

WINDSOR
CONSENT TO PARTICIPATE IN RESEARCH
Title of Study: Examining the Physiological and Psychological Impact of
Smoking Cessation on Patients with Acute Myocardial Infarction (AMI): A
Comparison of Smokers and Non-Smokers
You are asked to participate in a research study conducted by Kathryn Pfaff, a
registered nurse who is also a Master's student in Nursing, and her faculty
advisor, Dr. Maher El-Masri, from the Faculty of Nursing at the University of
Windsor. The findings of this study will be used to partially fulfil the requirements
for Kathryn Pfaff s Master's degree.
If you have any questions or concerns about the research, please feel to contact
Kathy Pfaff at (XXX) XXX-XXXX or Dr. El-Masri at (519) 253-3000, ext. 2400.
PURPOSE OF THE STUDY
The purpose of this study is to learn more about how smoking withdrawal
influences the stress levels of people who have experienced an acute myocardial
infarction (heart attack).

PROCEDURES
If you volunteer to participate in this study, we would ask you to do the following
things:
1. Report your current smoking status (smoker or non-smoker) to the
research team.
2. Complete a 20 minute survey package which will be explained to you by a
member of the research team. You will be asked to record your answers
on a form. The interview will take place at the hospital 2 days after your
admission. The survey package consists to three questionnaires:
The first asks questions about your stress levels during your
hospitalization; the second asks questions about your sleeping patterns;
and the third asks questions about your medical and smoking history
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3. Agree to allow a member of the research team to gather some
information about your medical history from your medical record.
POTENTIAL RISKS AND DISCOMFORTS
The risks associated with participating in this study are minimal. That is, the risks
or discomforts are similar to those that a heart patient would experience in the
period of time following a heart attack. Because heart patients often experience
fatigue or tiredness following a heart attack, completion of the survey package
may contribute to this feeling of fatigue. If this occurs, you may complete the
survey package as your energy level permits. In addition, it is possible that an
awareness of stress, and/or smoking withdrawal symptoms may increase your
stress. All patients in a CCU are monitored for the physical and emotional
complications of increased stress following a heart attack. You are advised to
report any symptoms of increased stress, such as anxiety, depression, chest
pain or other heart symptoms to the CCU staff. Finally, it is possible that you may
find some questions to be personal and/or troubling to you. You may choose to
not answer any question(s) that you feel is too intrusive and you may withdraw
from participation at any time without any penalty. There may also be risks or
discomforts involved in taking part of this study that are not known to the
researchers at this time.
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
It is unlikely that you will experience any direct health benefits by participating in
this study. However, it is hoped that you will feel some satisfaction in knowing
that you have added to the knowledge that health professionals have about how
smoking withdrawal affects the physical and emotional health of heart attack
patients. It is also hoped that the knowleged gained from this study will assist
health care professionals to better address the stress of patients who are
hospitalized for AMI. The results of this study may assist nurses to develop
strategies to reduce the stress associated with sudden smoking withdrawal
following heart attack. Reductions in stress may hopefully reduce the number of
complications and deaths that occur from heart attacks. Furthermore, reporting of
the results of this study may serve as an incentive for those who smoke to quit
smoking. Finally, the results of this study may provide support for further
research studies which test the best types of smoking cessation strategies for
heart attack patients when they are hospitalized.
PAYMENT FOR PARTICIPATION
You will not receive any payment for participating in this study.

80

CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be
identified with you will remain confidential and will be disclosed only with your
permission. All hard copies of your data will be stored in a locked cabinet in the
researcher's office. Data will be kept for 5 years for possible use in future studies,
following which, the data will be shredded.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in this
study, you may withdraw at any time without consequences of any kind. The
care and treatment that you receive will not be affected if you choose not to
participate in the study. You may also refuse to answer any questions you don't
want to answer and still remain in the study. The investigator may withdraw you
from this research if circumstances arise which warrant doing so. You may also
choose to withdraw your information from the study.

FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
The research findings will be published on the Research Ethics Board website at
the University of Windsor (www.uwindsor.ca/reb). You may also contact Kathy
Pfaff directly (519-735-3522 or kpfaff@uwindsor.ca) for final results of the study.
SUBSEQUENT USE OF DATA
This data may be used in future studies.
RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without
penalty. If you have questions regarding your rights as a research subject,
contact:
Research Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4;
telephone: 519-253-3000, ext. 3916; e-mail: lbunn@uwindsor
SIGNATURE OF RESEARCH SUBJECT
I understand the information provided for the study Examining the
Physiological and Psychological Impact of Smoking Cessation on Patients
with Acute Myocardial Infarction: A Comparison of Smokers and Smokers
as described herein. My questions have been answered to my satisfaction, and I
agree to participate in this study. I have been given a copy of this form.
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Name of Subject
Signature of Subject

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.

Name of Investigator

Signature of Investigator

Date
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ft
WINDSOR
LETTER OF INFORMATION FOR CONSENT TO PARTICIPATE IN
RESEARCH
Title of Study: Examining the Physiological and Psychological Impact of
Smoking Cessation on Patients with Acute Myocardial Infarction (AMI):
A Comparison of Smokers and Non-smokers
You are asked to participate in a research study conducted by Kathryn Pfaff RN
and Master's student in Nursing, and her faculty advisor, Dr. Maher El-Masri,
from the Faculty of Nursing at the University of Windsor. The findings of this
study will be used to partially fulfil the requirements for Kathryn Pfaff s Master's
degree.
If you have any questions or concerns about the research, please feel to contact
Kathy Pfaff at (XXX) XXX-XXXX or Dr. El-Masri at (519) 253-3000.
PURPOSE OF THE STUDY
The purpose of this study is to learn more about how smoking withdrawal
influences the stress levels of people who have experienced an acute myocardial
infarction (heart attack).

PROCEDURES
If you volunteer to participate in this study, we would ask you to do the following
things:
1. Report your current smoking status (smoker or non-smoker) to the
research team.
2. Complete a 20 minute survey package which will be explained to you by a
member of the research team. You will be asked to record your answers
on a form. The interview will take place at the hospital 2 days after your
admission. The survey package consists of three questionnaires: The first
asks questions about your stress levels during your hospitalization; the
second asks questions about your sleeping patterns; and the third asks
questions about your medical and smoking history.
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3. Agree to allow a member of the research team to gather some information
about your medical history from your medical record.
POTENTIAL RISKS AND DISCOMFORTS
The risks associated with participating in this study are minimal. That is, the risks
or discomforts are similar to those that a heart patient would experience in the
period of time following a heart attack. Because heart patients often experience
fatigue or tiredness following a heart attack, completion of the survey package
may contribute to this feeling of fatigue. If this occurs, you may complete the
survey package as your energy level permits. In addition, it is possible that an
awareness of stress, and/or smoking withdrawal symptoms may increase your
stress. All patients in a CCU are monitored for the physical and emotional
complications of increased stress following a heart attack. You are advised to
report any symptoms of increased stress, such as anxiety, depression, chest
pain or other heart symptoms to the CCU staff. Finally, it is possible that you may
find some questions to be personal and/or troubling to you. You may choose to
not answer any question(s) that you feel is too intrusive and you may withdraw
from participation at any time without any penalty. There may also be risks or
discomforts involved in taking part of this study that are not known to the
researchers at this time.
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
It is unlikely that you will experience any direct health benefits by participating in
this study. However, it is hoped that you will feel some satisfaction in knowing
that you have added to the knowledge that health professionals have about how
smoking withdrawal affects the physical and emotional health of heart attack
patients. It is also hoped that the knowleged gained from this study will assist
health care professionals to better address the stress of patients who are
hospitalized for AMI. The results of this study may assist nurses to develop
strategies to reduce the stress associated with sudden smoking withdrawal
following heart attack. Reductions in stress may hopefully reduce the number of
complications and deaths that occur from heart attacks. Furthermore, reporting of
the results of this study may serve as an incentive for those who smoke to quit
smoking. Finally, the results of this study may provide support for further
research studies which test the best types of smoking cessation strategies for
heart attack patients when they are hospitalized.
PAYMENT FOR PARTICIPATION
You will not receive any payment for participating in this study.
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CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be
identified with you will remain confidential and will be disclosed only with your
permission. All hard copies of your data will be stored in a locked cabinet in the
researcher's office. Data will be kept for 5 years for possible use in future studies,
following which, the data will be shredded.
PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not. If you volunteer to be in this
study, you may withdraw at any time without consequences of any kind. The
care and treatment that you receive will not be affected if you choose not to
participate in the study. You may also refuse to answer any questions you don't
want to answer and still remain in the study. The investigator may withdraw you
from this research if circumstances arise which warrant doing so. You may also
choose to withdraw your information from the study.

FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
The research findings will be published on the Research Ethics Board website at
the University of Windsor (www.uwindsor.ca/reb). You may also contact Kathy
Pfaff directly (XXX-XXX-XXXX or kpfaff@uwindsor.ca) for final results of the
study.
SUBSEQUENT USE OF DATA
This data may be used in future studies.
RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without
penalty. If you have questions regarding your rights as a research subject,
contact:
Research Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4;
telephone: 519-253-3000, ext. 3916; e-mail: lbunn@uwindsor.
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APPENDIX C
Instructions for Recruitment of Subjects
Screen patients for eligibility:
Inclusion
•
•
•

18 years of age and older with a confirmed diagnosis of AMI who are clinically
stable
Able to read and understand English
Clinically stable

Exclusion
•
•
•
•

Unstable patients - those requiring vasoactive medications (except nitroglycerin)
and/or mechanical ventilation.
A history of diagnosis with anxiety or depressive disorders.
Patients involved in a smoking cessation program prior to hospital admission.
Patients not admitted to CCUfromhome i.e. not transferred from another unit or
hospital.

Approach the subject on day two after admission to the CCU:
"Hi Mr./Ms.

, my name is
and I am
(state your relationship to the patient - e.g. staff nurse on the
unit/reseach assistant). I am also part of a team of researchers doing a study to find out
about how smoking withdrawal affects the stress levels and the recovery of people who
have experienced a heart attack. Would you mind answering a few questions to see if you
would be eligible to participate in the study?
1. Are you a smoker - this includes any nicotine product (cigarettes, pipe, cigars,
chewing tobacco). If yes, were you using anything to help you quit smoking
before you were admitted to the hospital?
2. Are you being by your doctor treated for anxiety or depression?"
If he/she doesn't qualify, explain this and thank him/her.
If he/she does qualify explain that:
"You qualify to participate in this study. The purpose of this study is to determine if there
is a difference in the stress levels and recovery between smokers and non-smokers who
have had a heart attack. If you choose to participate I will leave with you a survey
package that you may complete as you feel able. The survey asks questions about:
• The symptoms of stress that you are feeling right now
• Your sleeping patterns right now
• Yourself and your health
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It will take you about 15 to 20 minutes. We will also record some information about your
medical history from your chart. I will give you a copy of the information that will be
taken from your chart. Would you consider participating in this study?"
If yes, review the consent form with the patient, including the chart data form.
Ensure that he/she understands the risks, benefits, and that participation is
voluntary. The patient signs two copies of the consent and keeps one for him/herself.
The patient also keeps the letter of information. Once the patient completes the
survey, ask him/her to seal the envelope and place it in the drop box. Record the
patient code, room number and medical record number and smoking status in the
log book.
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